A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
Infections with bacteria of the genus STAPHYLOCOCCUS.
Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative.
Substances that reduce the growth or reproduction of BACTERIA.
One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
A plant genus of the family APOCYNACEAE that contains bisindole alkaloids and IBOGAINE.
Infections to the skin caused by bacteria of the genus STAPHYLOCOCCUS.
An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
Any infection which a patient contracts in a health-care institution.
A part of the upper respiratory tract. It contains the organ of SMELL. The term includes the external nose, the nasal cavity, and the PARANASAL SINUSES.
Glycopeptide antibiotic complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety.
A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
Nonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
Using MOLECULAR BIOLOGY techniques, such as DNA SEQUENCE ANALYSIS; PULSED-FIELD GEL ELECTROPHORESIS; and DNA FINGERPRINTING, to identify, classify, and compare organisms and their subtypes.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Infection occurring at the site of a surgical incision.
Proteins found in any species of bacterium.
The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.
Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms.
A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.
Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen.
Nonsusceptibility of an organism to the action of penicillins.
Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents.
Formation or presence of a blood clot (THROMBUS) in the CAVERNOUS SINUS of the brain. Infections of the paranasal sinuses and adjacent structures, CRANIOCEREBRAL TRAUMA, and THROMBOPHILIA are associated conditions. Clinical manifestations include dysfunction of cranial nerves III, IV, V, and VI, marked periorbital swelling, chemosis, fever, and visual loss. (From Adams et al., Principles of Neurology, 6th ed, p711)
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
Bacteria which retain the crystal violet stain when treated by Gram's method.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment.
A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA.
A broad-spectrum antimicrobial carboxyfluoroquinoline.
I'm sorry for any confusion, but "India" is not a medical term that can be defined in a medical context. It is a geographical location, referring to the Republic of India, a country in South Asia. If you have any questions related to medical topics or definitions, I would be happy to help with those!
Invasion of the site of trauma by pathogenic microorganisms.
Gel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.
Viruses whose host is Staphylococcus.
A plant genus of the family ASTERACEAE that contains PYRROLIZIDINE ALKALOIDS. Yellow vein disease of Ageratum is caused by a viral DNA complex of a begomovirus (GEMINIVIRIDAE).
Deoxyribonucleic acid that makes up the genetic material of bacteria.
Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. (From Cecil Textbook of Medicine, 19th ed, p1688)
Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.
Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.
A semi-synthetic antibiotic related to penicillin.
Institutions with an organized medical staff which provide medical care to patients.
One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
A protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IMMUNOGLOBULIN G. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function.
The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
A species of STAPHYLOCOCCUS found on the skin of humans (and non-human primates), often causing hospital-acquired infections (CROSS INFECTION).
A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486)
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
Techniques used in studying bacteria.
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.
Bacterial proteins that share the property of binding irreversibly to PENICILLINS and other ANTIBACTERIAL AGENTS derived from LACTAMS. The penicillin-binding proteins are primarily enzymes involved in CELL WALL biosynthesis including MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PEPTIDE SYNTHASES; TRANSPEPTIDASES; and HEXOSYLTRANSFERASES.
A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)
A 25-kDa peptidase produced by Staphylococcus simulans which cleaves a glycine-glcyine bond unique to an inter-peptide cross-bridge of the STAPHYLOCOCCUS AUREUS cell wall. EC 3.4.24.75.
The functional hereditary units of BACTERIA.
Enzyme which catalyzes the peptide cross-linking of nascent CELL WALL; PEPTIDOGLYCAN.
Enzymes that catalyze the transfer of hexose groups. EC 2.4.1.-.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
Acyltransferases that use AMINO ACYL TRNA as the amino acid donor in formation of a peptide bond. There are ribosomal and non-ribosomal peptidyltransferases.
Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.
A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
Pneumonia caused by infections with bacteria of the genus STAPHYLOCOCCUS, usually with STAPHYLOCOCCUS AUREUS.
A beta-lactamase preferentially cleaving penicillins. (Dorland, 28th ed) EC 3.5.2.-.
A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.
Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard.
A technique of bacterial typing which differentiates between bacteria or strains of bacteria by their susceptibility to one or more bacteriophages.
A technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population.
A genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus.
A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.
A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
Infections by bacteria, general or unspecified.
The proximal portion of the respiratory passages on either side of the NASAL SEPTUM. Nasal cavities, extending from the nares to the NASOPHARYNX, are lined with ciliated NASAL MUCOSA.
Encrustations, formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedding in extracellular polymers, that adhere to surfaces such as teeth (DENTAL DEPOSITS); PROSTHESES AND IMPLANTS; and catheters. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and antifouling agents.
The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.
An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis.
Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.
Peptidoglycan is a complex, cross-linked polymer of carbohydrates and peptides that forms the rigid layer of the bacterial cell wall, providing structural support and protection while contributing to the bacterium's susceptibility or resistance to certain antibiotics.
The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents.
INFLAMMATION of the UDDER in cows.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Staphylococcal vaccines are prophylactic agents developed to prevent infections caused by Staphylococcus aureus, a pathogenic bacterium that frequently colonizes human skin and mucous membranes, often targeting surface proteins or toxins for immune response induction.
Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria.
The L-isomer of Ofloxacin.
A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria.
Rupture of bacterial cells due to mechanical force, chemical action, or the lytic growth of BACTERIOPHAGES.
Protein exotoxins from Staphylococcus aureus, phage type II, which cause epidermal necrolysis. They are proteins with a molecular weight of 26,000 to 32,000. They cause a condition variously called scaled skin, Lyell or Ritter syndrome, epidermal exfoliative disease, toxic epidermal necrolysis, etc.
'Osteomyelitis' is a medical condition defined as an inflammation or infection of the bone or marrow, often caused by bacteria or fungi, which can lead to symptoms such as pain, swelling, warmth, and redness in the affected area, and may require antibiotics or surgical intervention for treatment.
A cephalosporin antibiotic.
Bacterial polysaccharides that are rich in phosphodiester linkages. They are the major components of the cell walls and membranes of many bacteria.
Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
Ability of a microbe to survive under given conditions. This can also be related to a colony's ability to replicate.
A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.
An infant during the first month after birth.
A species of STAPHYLOCOCCUS similar to STAPHYLOCOCCUS HAEMOLYTICUS, but containing different esterases. The subspecies Staphylococcus hominis novobiosepticus is highly virulent and novobiocin resistant.
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Elements of limited time intervals, contributing to particular results or situations.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both.
Microbial antigens that have in common an extremely potent activating effect on T-cells that bear a specific variable region. Superantigens cross-link the variable region with class II MHC proteins regardless of the peptide binding in the T-cell receptor's pocket. The result is a transient expansion and subsequent death and anergy of the T-cells with the appropriate variable regions.
Structures within the nucleus of bacterial cells consisting of or containing DNA, which carry genetic information essential to the cell.
The spontaneous disintegration of tissues or cells by the action of their own autogenous enzymes.
Proteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS.
Transport proteins that carry specific substances in the blood or across cell membranes.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity.
A method where a culturing surface inoculated with microbe is exposed to small disks containing known amounts of a chemical agent resulting in a zone of inhibition (usually in millimeters) of growth of the microbe corresponding to the susceptibility of the strain to the agent.
Poisoning by staphylococcal toxins present in contaminated food.
Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells.
The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.
An autolytic enzyme bound to the surface of bacterial cell walls. It catalyzes the hydrolysis of the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell wall glycopeptides, particularly peptidoglycan. EC 3.5.1.28.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight.
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram's method.
The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
INFLAMMATION of the BREAST, or MAMMARY GLAND.
Cell-surface components or appendages of bacteria that facilitate adhesion (BACTERIAL ADHESION) to other cells or to inanimate surfaces. Most fimbriae (FIMBRIAE, BACTERIAL) of gram-negative bacteria function as adhesins, but in many cases it is a minor subunit protein at the tip of the fimbriae that is the actual adhesin. In gram-positive bacteria, a protein or polysaccharide surface layer serves as the specific adhesin. What is sometimes called polymeric adhesin (BIOFILMS) is distinct from protein adhesin.
Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
Infections resulting from the implantation of prosthetic devices. The infections may be acquired from intraoperative contamination (early) or hematogenously acquired from other sites (late).
A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.
A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.

A new radical scavenging anthracene glycoside, asperflavin ribofuranoside, and polyketides from a marine isolate of the fungus microsporum. (1/2129)

A new anthracene glycoside, asperflavin ribofuranoside (1), and the previously described polyketides, flavoglaucin (2), isodihydroauroglaucin (3), and citrinin (4) have been isolated from the marine-derived fungus Microsporum sp. The structure and absolute stereochemistry of a new compound (1) was assigned on the basis of physicochemical data. Compounds 1-3 exhibited a significant radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) with IC(50) values of 14.2, 11.3, and 11.5 microM, respectively, which are more potent than the positive control, ascorbic acid (IC(50), 20 microM). Compound 1 also showed a moderate antibacterial activity against the methicillin-resistant and multidrug-resistant Staphylococcus aureus (MRSA and MDRSA) with MIC value of 50 microg/ml.  (+info)

In vitro screening of five local medicinal plants for antibacterial activity using disc diffusion method. (2/2129)

Medicinal plants have many traditional claims including the treatment of ailments of infectious origin. In the evaluation of traditional claims, scientific research is important. The objective of the study was to determine the presence of antibacterial activity in the crude extracts of some of the commonly used medicinal plants in Malaysia, Andrographis paniculata, Vitex negundo, Morinda citrifolia, Piper sarmentosum, and Centella asiatica. In this preliminary investigation, the leaves were used and the crude extracts were subjected to screening against five strains of bacteria species, Methicillin Resistant Staphylococcus aureus (MRSA), Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa and Escherichia coli, using standard protocol of Disc Diffusion Method (DDM). The antibacterial activities were assessed by the presence or absence of inhibition zones and MIC values. M. citrifolia, P. sarmentosum and C. asiatica methanol extract and A. paniculata (water extract) have potential antibacterial activities to both gram positive S. aureus and Methicillin Resistant S. aureus (MRSA). None of the five plant extracts tested showed antibacterial activities to gram negative E. coli and K. pneumoniae, except for A. paniculata and P. sarmentosum which showed activity towards P. aeruginosa. A. paniculata being the most potent at MIC of 2 g/disc. This finding forms a basis for further studies on screening of local medicinal plant extracts for antibacteria properties.  (+info)

An outbreak of severe infections with community-acquired MRSA carrying the Panton-Valentine leukocidin following vaccination. (3/2129)

BACKGROUND: Infections with community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) are emerging worldwide. We investigated an outbreak of severe CA-MRSA infections in children following out-patient vaccination. METHODS AND FINDINGS: We carried out a field investigation after adverse events following immunization (AEFI) were reported. We reviewed the clinical data from all cases. S. aureus recovered from skin infections and from nasal and throat swabs were analyzed by pulse-field gel electrophoresis, multi locus sequence typing, PCR and microarray. In May 2006, nine children presented with AEFI, ranging from fatal toxic shock syndrome, necrotizing soft tissue infection, purulent abscesses, to fever with rash. All had received a vaccination injection in different health centres in one District of Ho Chi Minh City. Eight children had been vaccinated by the same health care worker (HCW). Deficiencies in vaccine quality, storage practices, or preparation and delivery were not found. Infection control practices were insufficient. CA-MRSA was cultured in four children and from nasal and throat swabs from the HCW. Strains from children and HCW were indistinguishable. All carried the Panton-Valentine leukocidine (PVL), the staphylococcal enterotoxin B gene, the gene complex for staphylococcal-cassette-chromosome mec type V, and were sequence type 59. Strain HCM3A is epidemiologically unrelated to a strain of ST59 prevalent in the USA, although they belong to the same lineage. CONCLUSIONS: We describe an outbreak of infections with CA-MRSA in children, transmitted by an asymptomatic colonized HCW during immunization injection. Consistent adherence to injection practice guidelines is needed to prevent CA-MRSA transmission in both in- and outpatient settings.  (+info)

Inhibition of beta-lactamase-mediated oxacillin resistance in Staphylococcus aureus by a deoxyribozyme. (4/2129)

AIM: To investigate the oxacillin susceptibility restoration of methicillin-resistant Staphylococcus aureus (MRSA) by targeting the signaling pathway of blaR1- blaZ with a DNAzyme. METHODS: A DNAzyme (named PS-DRz602) targeting blaR1 mRNA was designed and synthesized. After DRz602 was introduced into a MRSA strain WHO-2, the colony-forming units of WHO-2 on the Mueller-Hinton agar containing 6 mg/L oxacillin and the minimum inhibitory concentrations of oxacillin were determined. The inhibitory effects of DRz602 on the expressions of antibiotic- resistant gene blaR1 and its downstream gene blaZ were detected by real time RT-PCR. RESULTS: PS-DRz602 significantly decreased the transcription of blaR1 mRNA and led to the significant reduction of blaZ in a concentration-dependent manner. Consequently, the resistance of S aureus WHO-2 to the beta-lactam antibiotic oxacillin was significantly inhibited. CONCLUSION: Our results indicated that blocking the blaR1-blaZ signaling pathway via DNAzyme might provide a viable strategy for inhibiting the resistance of MRSA to beta-lactam antibiotics and that BlaR1 might be a potential target for pharmacological agents combating MRSA.  (+info)

Pharmacodynamics of minocycline against Staphylococcus aureus in an in vitro pharmacokinetic model. (5/2129)

 (+info)

Effects of extracts from Italian medicinal plants on planktonic growth, biofilm formation and adherence of methicillin-resistant Staphylococcus aureus. (6/2129)

 (+info)

Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. (7/2129)

 (+info)

Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. (8/2129)

 (+info)

Methicillin-Resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to many antibiotics, including methicillin and other related antibiotics such as oxacillin, penicillin, and amoxicillin. This bacterium can cause a range of infections, from skin infections to more severe and potentially life-threatening conditions such as pneumonia, bloodstream infections, and surgical site infections.

MRSA is often associated with healthcare settings, where it can spread through contaminated surfaces, equipment, and direct contact with an infected person or carrier. However, community-associated MRSA (CA-MRSA) has also emerged as a significant public health concern, causing infections outside of healthcare facilities, such as in schools, gyms, and other community settings.

It's important to note that while MRSA is resistant to certain antibiotics, there are still some treatment options available for MRSA infections, including vancomycin, linezolid, daptomycin, and others. However, the emergence of MRSA strains with reduced susceptibility to these antibiotics has become a growing concern, highlighting the importance of infection control measures and the development of new antimicrobial agents.

Staphylococcus aureus is a type of gram-positive, round (coccal) bacterium that is commonly found on the skin and mucous membranes of warm-blooded animals and humans. It is a facultative anaerobe, which means it can grow in the presence or absence of oxygen.

Staphylococcus aureus is known to cause a wide range of infections, from mild skin infections such as pimples, impetigo, and furuncles (boils) to more severe and potentially life-threatening infections such as pneumonia, endocarditis, osteomyelitis, and sepsis. It can also cause food poisoning and toxic shock syndrome.

The bacterium is often resistant to multiple antibiotics, including methicillin, which has led to the emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains that are difficult to treat. Proper hand hygiene and infection control practices are critical in preventing the spread of Staphylococcus aureus and MRSA.

Staphylococcal infections are a type of infection caused by Staphylococcus bacteria, which are commonly found on the skin and nose of healthy people. However, if they enter the body through a cut, scratch, or other wound, they can cause an infection.

There are several types of Staphylococcus bacteria, but the most common one that causes infections is Staphylococcus aureus. These infections can range from minor skin infections such as pimples, boils, and impetigo to serious conditions such as pneumonia, bloodstream infections, and toxic shock syndrome.

Symptoms of staphylococcal infections depend on the type and severity of the infection. Treatment typically involves antibiotics, either topical or oral, depending on the severity and location of the infection. In some cases, hospitalization may be necessary for more severe infections. It is important to note that some strains of Staphylococcus aureus have developed resistance to certain antibiotics, making them more difficult to treat.

"Methicillin resistance" is a term used in medicine to describe the resistance of certain bacteria to the antibiotic methicillin and other related antibiotics, such as oxacillin and nafcillin. This type of resistance is most commonly associated with Staphylococcus aureus (MRSA) and coagulase-negative staphylococci (MRCoNS) bacteria.

Bacteria that are methicillin-resistant have acquired the ability to produce an additional penicillin-binding protein, known as PBP2a or PBP2'', which has a low affinity for beta-lactam antibiotics, including methicillin. This results in the bacteria being able to continue growing and dividing despite the presence of these antibiotics, making infections caused by these bacteria more difficult to treat.

Methicillin resistance is a significant concern in healthcare settings, as it can lead to increased morbidity, mortality, and healthcare costs associated with treating infections caused by these bacteria. In recent years, there has been an increase in the prevalence of methicillin-resistant bacteria, highlighting the need for ongoing surveillance, infection control measures, and the development of new antibiotics to treat these infections.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Methicillin is defined as a narrow-spectrum antibiotic that belongs to the penicillin class. It was initially developed to address the problem of beta-lactamase enzyme production in Staphylococcus aureus bacteria, which made them resistant to earlier penicillins. However, methicillin-resistant strains of S. aureus (MRSA) have since emerged and become a significant global health concern. Methicillin is no longer used clinically due to its high nephrotoxicity, but the term "methicillin-resistant" remains relevant in describing resistant bacteria.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

"Tabernaemontana" is a genus of evergreen trees and shrubs in the dogbane family, Apocynaceae. It includes around 100 species that are native to tropical regions of the Americas, Africa, and Asia. Some species of Tabernaemontana contain alkaloids, which have been used in traditional medicine for various purposes, such as treating pain, inflammation, and gastrointestinal disorders. However, it is important to note that these compounds can also be toxic if not used properly, so they should only be administered under the guidance of a qualified healthcare professional.

Staphylococcal skin infections are a type of skin infection caused by Staphylococcus aureus (S. aureus) bacteria, which commonly live on the skin and inside the nose without causing harm. However, if they enter the body through a cut or scratch, they can cause an infection.

There are several types of staphylococcal skin infections, including:

1. Impetigo: A highly contagious superficial skin infection that typically affects children and causes red, fluid-filled blisters that burst and leave a yellowish crust.
2. Folliculitis: An inflammation of the hair follicles that causes red, pus-filled bumps or pimples on the skin.
3. Furunculosis: A deeper infection of the hair follicle that forms a large, painful lump or boil under the skin.
4. Cellulitis: A potentially serious bacterial infection that affects the deeper layers of the skin and can cause redness, swelling, warmth, and pain in the affected area.
5. Abscess: A collection of pus that forms in the skin, often caused by a staphylococcal infection.

Treatment for staphylococcal skin infections typically involves antibiotics, either topical or oral, depending on the severity and location of the infection. In some cases, drainage of pus or other fluids may be necessary to promote healing. Preventing the spread of staphylococcal skin infections involves good hygiene practices, such as washing hands frequently, covering wounds and cuts, and avoiding sharing personal items like towels or razors.

Oxacillin is a type of antibiotic known as a penicillinase-resistant penicillin. It is used to treat infections caused by bacteria that are resistant to other types of penicillins. Oxacillin is commonly used to treat infections of the skin, soft tissue, and bone.

Here is the medical definition of oxacillin:

Oxacillin is a semisynthetic antibiotic derived from penicillin that is resistant to staphylococcal penicillinases. It is used to treat infections caused by susceptible strains of staphylococci and some streptococci, including penicillinase-producing staphylococci. Oxacillin is available as a sterile powder for injection or as a oral capsule.

It is important to note that the overuse or misuse of antibiotics like oxacillin can lead to the development of antibiotic resistance, which makes infections harder to treat. It's essential to use antibiotics only when necessary and as directed by a healthcare professional.

Vancomycin is an antibiotic that belongs to the glycopeptide class. It is primarily used to treat severe infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Vancomycin works by inhibiting the synthesis of bacterial cell walls. It is usually administered intravenously in a hospital setting due to its potential nephrotoxicity and ototoxicity. The medical definition of 'Vancomycin' can be summarized as:

"A glycopeptide antibiotic used to treat severe infections caused by Gram-positive bacteria, particularly those that are resistant to other antibiotics. It inhibits bacterial cell wall synthesis and is administered intravenously due to its potential nephrotoxicity and ototoxicity."

Cross infection, also known as cross-contamination, is the transmission of infectious agents or diseases between patients in a healthcare setting. This can occur through various means such as contaminated equipment, surfaces, hands of healthcare workers, or the air. It is an important concern in medical settings and measures are taken to prevent its occurrence, including proper hand hygiene, use of personal protective equipment (PPE), environmental cleaning and disinfection, and safe injection practices.

A nose, in a medical context, refers to the external part of the human body that is located on the face and serves as the primary organ for the sense of smell. It is composed of bone and cartilage, with a thin layer of skin covering it. The nose also contains nasal passages that are lined with mucous membranes and tiny hairs known as cilia. These structures help to filter, warm, and moisturize the air we breathe in before it reaches our lungs. Additionally, the nose plays an essential role in the process of verbal communication by shaping the sounds we make when we speak.

Teicoplanin is a glycopeptide antibiotic that is primarily used in the treatment of serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). It works by inhibiting the biosynthesis of bacterial cell walls.

Teicoplanin has a long half-life, which allows for once- or twice-daily dosing, and it is available in both intravenous and intramuscular formulations. Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as local reactions at the injection site. Nephrotoxicity and ototoxicity are potential rare but serious adverse effects associated with teicoplanin use.

It is important to note that teicoplanin, like other glycopeptide antibiotics, should be used judiciously due to the risk of promoting antibiotic resistance and the potential for serious side effects.

Staphylococcus is a genus of Gram-positive, facultatively anaerobic bacteria that are commonly found on the skin and mucous membranes of humans and other animals. Many species of Staphylococcus can cause infections in humans, but the most notable is Staphylococcus aureus, which is responsible for a wide range of illnesses, from minor skin infections to life-threatening conditions such as pneumonia, endocarditis, and sepsis.

Staphylococcus species are non-motile, non-spore forming, and typically occur in grape-like clusters when viewed under a microscope. They can be coagulase-positive or coagulase-negative, with S. aureus being the most well-known coagulase-positive species. Coagulase is an enzyme that causes the clotting of plasma, and its presence is often used to differentiate S. aureus from other Staphylococcus species.

These bacteria are resistant to many commonly used antibiotics, including penicillin, due to the production of beta-lactamases. Methicillin-resistant Staphylococcus aureus (MRSA) is a particularly problematic strain that has developed resistance to multiple antibiotics and can cause severe, difficult-to-treat infections.

Proper hand hygiene, use of personal protective equipment, and environmental cleaning are crucial measures for preventing the spread of Staphylococcus in healthcare settings and the community.

Vancomycin resistance refers to the ability of certain bacteria to resist the antibiotic effects of vancomycin, which is a glycopeptide antibiotic used to treat severe infections caused by gram-positive bacteria. This resistance develops due to genetic changes that result in the alteration of the bacterial cell wall, making it difficult for vancomycin to bind and inhibit bacterial growth.

There are several types of vancomycin resistance mechanisms, with the most common ones being VanA, VanB, VanC, VanD, VanE, and VanG. Among these, VanA and VanB are clinically significant as they confer high-level resistance to vancomycin and teicoplanin, another glycopeptide antibiotic.

Vancomycin-resistant bacteria can cause various difficult-to-treat infections, such as urinary tract infections, bloodstream infections, and wound infections. These infections often occur in healthcare settings, including hospitals and long-term care facilities, where the use of antibiotics is more frequent. The spread of vancomycin resistance is a significant public health concern, as it limits treatment options for severe bacterial infections and can lead to worse patient outcomes.

Community-acquired infections are those that are acquired outside of a healthcare setting, such as in one's own home or community. These infections are typically contracted through close contact with an infected person, contaminated food or water, or animals. Examples of community-acquired infections include the common cold, flu, strep throat, and many types of viral and bacterial gastrointestinal infections.

These infections are different from healthcare-associated infections (HAIs), which are infections that patients acquire while they are receiving treatment for another condition in a healthcare setting, such as a hospital or long-term care facility. HAIs can be caused by a variety of factors, including contact with contaminated surfaces or equipment, invasive medical procedures, and the use of certain medications.

It is important to note that community-acquired infections can also occur in healthcare settings if proper infection control measures are not in place. Healthcare providers must take steps to prevent the spread of these infections, such as washing their hands regularly, using personal protective equipment (PPE), and implementing isolation precautions for patients with known or suspected infectious diseases.

Molecular typing is a laboratory technique used to identify and characterize specific microorganisms, such as bacteria or viruses, at the molecular level. This method is used to differentiate between strains of the same species based on their genetic or molecular differences. Molecular typing techniques include methods such as pulsed-field gel electrophoresis (PFGE), multiple-locus variable number tandem repeat analysis (MLVA), and whole genome sequencing (WGS). These techniques allow for high-resolution discrimination between strains, enabling epidemiological investigations of outbreaks, tracking the transmission of pathogens, and studying the evolution and population biology of microorganisms.

Multiple bacterial drug resistance (MDR) is a medical term that refers to the resistance of multiple strains of bacteria to several antibiotics or antimicrobial agents. This means that these bacteria have developed mechanisms that enable them to survive and multiply despite being exposed to drugs that were previously effective in treating infections caused by them.

MDR is a significant public health concern because it limits the treatment options available for bacterial infections, making them more difficult and expensive to treat. In some cases, MDR bacteria may cause severe or life-threatening infections that are resistant to all available antibiotics, leaving doctors with few or no effective therapeutic options.

MDR can arise due to various mechanisms, including the production of enzymes that inactivate antibiotics, changes in bacterial cell membrane permeability that prevent antibiotics from entering the bacteria, and the development of efflux pumps that expel antibiotics out of the bacteria. The misuse or overuse of antibiotics is a significant contributor to the emergence and spread of MDR bacteria.

Preventing and controlling the spread of MDR bacteria requires a multifaceted approach, including the judicious use of antibiotics, infection control measures, surveillance, and research into new antimicrobial agents.

A surgical wound infection, also known as a surgical site infection (SSI), is defined by the Centers for Disease Control and Prevention (CDC) as an infection that occurs within 30 days after surgery (or within one year if an implant is left in place) and involves either:

1. Purulent drainage from the incision;
2. Organisms isolated from an aseptically obtained culture of fluid or tissue from the incision;
3. At least one of the following signs or symptoms of infection: pain or tenderness, localized swelling, redness, or heat; and
4. Diagnosis of surgical site infection by the surgeon or attending physician.

SSIs can be classified as superficial incisional, deep incisional, or organ/space infections, depending on the depth and extent of tissue involvement. They are a common healthcare-associated infection and can lead to increased morbidity, mortality, and healthcare costs.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

A carrier state is a condition in which a person carries and may be able to transmit a genetic disorder or infectious disease, but does not show any symptoms of the disease themselves. This occurs when an individual has a recessive allele for a genetic disorder or is infected with a pathogen, but does not have the necessary combination of genes or other factors required to develop the full-blown disease.

For example, in the case of cystic fibrosis, which is caused by mutations in the CFTR gene, a person who carries one normal allele and one mutated allele for the disease is considered a carrier. They do not have symptoms of cystic fibrosis themselves, but they can pass the mutated allele on to their offspring, who may then develop the disease if they inherit the mutation from both parents.

Similarly, in the case of infectious diseases, a person who is infected with a pathogen but does not show any symptoms may still be able to transmit the infection to others. This is known as being an asymptomatic carrier or a healthy carrier. For example, some people who are infected with hepatitis B virus (HBV) may not develop any symptoms of liver disease, but they can still transmit the virus to others through contact with their blood or other bodily fluids.

It's important to note that in some cases, carriers of certain genetic disorders or infectious diseases may have mild or atypical symptoms that do not meet the full criteria for a diagnosis of the disease. In these cases, they may be considered to have a "reduced penetrance" or "incomplete expression" of the disorder or infection.

Leukocidins are a type of protein toxin produced by some strains of bacteria. They are capable of lysing or destroying white blood cells (leukocytes), hence the name "leukocidins." These toxins contribute to the virulence of the bacteria, helping them evade the immune system and cause infection. A well-known example is Panton-Valentine leukocidin (PVL), which is produced by some strains of Staphylococcus aureus and has been associated with severe, invasive infections such as necrotizing pneumonia and skin abscesses.

Staphylococcus epidermidis is a type of coagulase-negative staphylococcal bacterium that is commonly found on the human skin and mucous membranes. It is a part of the normal flora and usually does not cause infection in healthy individuals. However, it can cause serious infections in people with weakened immune systems or when it enters the body through medical devices such as catheters or artificial joints. Infections caused by S. epidermidis are often difficult to treat due to its ability to form biofilms.

Medical Definition: Staphylococcus epidermidis is a gram-positive, catalase-positive, coagulase-negative coccus that commonly inhabits the skin and mucous membranes. It is a leading cause of nosocomial infections associated with indwelling medical devices and is known for its ability to form biofilms. S. epidermidis infections can cause a range of clinical manifestations, including bacteremia, endocarditis, urinary tract infections, and device-related infections.

Coagulase is a type of enzyme produced by some bacteria, including Staphylococcus aureus. This enzyme helps the bacteria to clot blood plasma by converting an inactive precursor (prothrombin) into thrombin, which then converts fibrinogen into fibrin to form a clot. The ability of S. aureus to produce coagulase is often used as a diagnostic criterion for this bacterium, and it also plays a role in the virulence of the organism by helping it to evade the host's immune system.

Penicillin resistance is the ability of certain bacteria to withstand the antibacterial effects of penicillin, a type of antibiotic. This occurs when these bacteria have developed mechanisms that prevent penicillin from binding to and inhibiting the function of their cell wall biosynthesis proteins, particularly the enzyme transpeptidase.

One common mechanism of penicillin resistance is the production of beta-lactamases, enzymes that can hydrolyze and inactivate the beta-lactam ring structure present in penicillin and other related antibiotics. Another mechanism involves alterations in the bacterial cell wall that prevent penicillin from binding to its target proteins.

Penicillin resistance is a significant concern in clinical settings, as it can limit treatment options for bacterial infections and may necessitate the use of more potent or toxic antibiotics. It is important to note that misuse or overuse of antibiotics can contribute to the development and spread of antibiotic-resistant bacteria, including those resistant to penicillin.

Oxazolidinones are a class of synthetic antibiotics that work by inhibiting bacterial protein synthesis. They bind to the 23S ribosomal RNA of the 50S subunit, preventing the formation of the initiation complex and thus inhibiting the start of protein synthesis.

The most well-known drug in this class is linezolid (Zyvox), which is used to treat serious infections caused by Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE).

Oxazolidinones are typically reserved for use in patients with serious infections who have failed other antibiotic treatments, due to concerns about the development of resistance and potential side effects such as myelosuppression and peripheral neuropathy.

Cavernous sinus thrombosis is a medical condition that refers to the formation of a blood clot (thrombus) in the cavernous sinuses, which are located near the base of the brain and are important for draining blood from the face and brain. This condition can occur as a complication of an infection in the facial area or sinuses, or it can be associated with other medical conditions such as cancer or trauma.

Symptoms of cavernous sinus thrombosis may include headache, fever, eye pain, swelling or bulging of the eyes, double vision, and decreased vision. If left untreated, this condition can lead to serious complications such as meningitis, brain abscess, or even death. Treatment typically involves administering antibiotics to treat any underlying infection and anticoagulants to prevent further clot formation. In some cases, surgery may be necessary to remove the clot.

Bacterial drug resistance is a type of antimicrobial resistance that occurs when bacteria evolve the ability to survive and reproduce in the presence of drugs (such as antibiotics) that would normally kill them or inhibit their growth. This can happen due to various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

As a result, bacterial infections may become more difficult to treat, requiring higher doses of medication, alternative drugs, or longer treatment courses. In some cases, drug-resistant infections can lead to serious health complications, increased healthcare costs, and higher mortality rates.

Examples of bacterial drug resistance include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug-resistant tuberculosis (MDR-TB). Preventing the spread of bacterial drug resistance is crucial for maintaining effective treatments for infectious diseases.

Acetamides are organic compounds that contain an acetamide functional group, which is a combination of an acetyl group (-COCH3) and an amide functional group (-CONH2). The general structure of an acetamide is R-CO-NH-CH3, where R represents the rest of the molecule.

Acetamides are found in various medications, including some pain relievers, muscle relaxants, and anticonvulsants. They can also be found in certain industrial chemicals and are used as intermediates in the synthesis of other organic compounds.

It is important to note that exposure to high levels of acetamides can be harmful and may cause symptoms such as headache, dizziness, nausea, and vomiting. Chronic exposure has been linked to more serious health effects, including liver and kidney damage. Therefore, handling and use of acetamides should be done with appropriate safety precautions.

Gram-positive bacteria are a type of bacteria that stain dark purple or blue when subjected to the Gram staining method, which is a common technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This staining method was developed by Hans Christian Gram in 1884.

The key characteristic that distinguishes Gram-positive bacteria from other types, such as Gram-negative bacteria, is the presence of a thick layer of peptidoglycan in their cell walls, which retains the crystal violet stain used in the Gram staining process. Additionally, Gram-positive bacteria lack an outer membrane found in Gram-negative bacteria.

Examples of Gram-positive bacteria include Staphylococcus aureus, Streptococcus pyogenes, and Bacillus subtilis. Some Gram-positive bacteria can cause various human diseases, while others are beneficial or harmless.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

Exotoxins are a type of toxin that are produced and released by certain bacteria into their external environment, including the surrounding tissues or host's bloodstream. These toxins can cause damage to cells and tissues, and contribute to the symptoms and complications associated with bacterial infections.

Exotoxins are typically proteins, and they can have a variety of effects on host cells, depending on their specific structure and function. Some exotoxins act by disrupting the cell membrane, leading to cell lysis or death. Others interfere with intracellular signaling pathways, alter gene expression, or modify host immune responses.

Examples of bacterial infections that are associated with the production of exotoxins include:

* Botulism, caused by Clostridium botulinum
* Diphtheria, caused by Corynebacterium diphtheriae
* Tetanus, caused by Clostridium tetani
* Pertussis (whooping cough), caused by Bordetella pertussis
* Food poisoning, caused by Staphylococcus aureus or Bacillus cereus

Exotoxins can be highly potent and dangerous, and some have been developed as biological weapons. However, many exotoxins are also used in medicine for therapeutic purposes, such as botulinum toxin (Botox) for the treatment of wrinkles or dystonia.

Daptomycin is a antibiotic medication used to treat serious skin infections and bloodstream infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive bacteria. It works by disrupting the bacterial cell membrane, leading to bacterial death. Daptomycin is administered intravenously and its use should be reserved for serious infections that cannot be treated with other antibiotics due to the risk of developing resistance.

Ciprofloxacin is a fluoroquinolone antibiotic that is used to treat various types of bacterial infections, including respiratory, urinary, and skin infections. It works by inhibiting the bacterial DNA gyrase, which is an enzyme necessary for bacterial replication and transcription. This leads to bacterial cell death. Ciprofloxacin is available in oral and injectable forms and is usually prescribed to be taken twice a day. Common side effects include nausea, diarrhea, and headache. It may also cause serious adverse reactions such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is important to note that ciprofloxacin should not be used in patients with a history of hypersensitivity to fluoroquinolones and should be used with caution in patients with a history of seizures, brain injury, or other neurological conditions.

I'm sorry for any confusion, but "India" is not a medical term or concept. It is a country in South Asia, the second-most populous country in the world, known for its rich history, diverse culture, and numerous contributions to various fields including medicine. If you have any questions related to medical topics, I would be happy to help answer them!

A wound infection is defined as the invasion and multiplication of microorganisms in a part of the body tissue, which has been damaged by a cut, blow, or other trauma, leading to inflammation, purulent discharge, and sometimes systemic toxicity. The symptoms may include redness, swelling, pain, warmth, and fever. Treatment typically involves the use of antibiotics and proper wound care. It's important to note that not all wounds will become infected, but those that are contaminated with bacteria, dirt, or other foreign substances, or those in which the skin's natural barrier has been significantly compromised, are at a higher risk for infection.

Pulsed-field gel electrophoresis (PFGE) is a type of electrophoresis technique used in molecular biology to separate DNA molecules based on their size and conformation. In this method, the electric field is applied in varying directions, which allows for the separation of large DNA fragments that are difficult to separate using traditional gel electrophoresis methods.

The DNA sample is prepared by embedding it in a semi-solid matrix, such as agarose or polyacrylamide, and then subjected to an electric field that periodically changes direction. This causes the DNA molecules to reorient themselves in response to the changing electric field, which results in the separation of the DNA fragments based on their size and shape.

PFGE is a powerful tool for molecular biology research and has many applications, including the identification and characterization of bacterial pathogens, the analysis of genomic DNA, and the study of gene organization and regulation. It is also used in forensic science to analyze DNA evidence in criminal investigations.

Staphylococcus phages do not have a specific medical definition, but I can provide you with some information about both concepts:

1. Staphylococcus: This term refers to a group of bacteria that can cause various infections in humans and animals. The most common species is Staphylococcus aureus, which often colonizes the skin and nasal passages of healthy individuals. However, it can lead to infections when it enters the body through wounds or other breaks in the skin.

2. Phages: These are viruses that infect and kill bacteria. They specifically target and replicate within bacterial cells, using the host's machinery for their reproduction. Once the phage has multiplied sufficiently, it causes the bacterial cell to lyse (burst), releasing new phage particles into the environment. Phages can be specific to certain bacterial species or strains, making them potential alternatives to antibiotics in treating bacterial infections without disrupting the normal microbiota.

When combining these two concepts, Staphylococcus phages refer to viruses that infect and kill Staphylococcus bacteria. These phages can be used as therapeutic agents to treat Staphylococcus infections, particularly those caused by antibiotic-resistant strains like methicillin-resistant Staphylococcus aureus (MRSA). However, it is essential to note that the use of phages as a treatment option is still an experimental approach and requires further research before becoming a widely accepted therapeutic strategy.

Ageratum is a genus of flowering plants in the daisy family, Asteraceae. It includes several species of annual and perennial herbs and shrubs that are native to tropical and subtropical regions of the Americas. The name "ageratum" comes from the Greek word "ageiro," which means "I grow old," referring to the belief that the plants have anti-aging properties.

The most commonly cultivated species is Ageratum houstonianum, also known as floss flower or bluemink. It is a popular ornamental plant grown for its attractive clusters of small, delicate flowers in shades of blue, purple, pink, and white. The plants are low-growing and bushy, making them suitable for borders, edgings, and containers.

In addition to their ornamental value, some species of ageratum have been used in traditional medicine for their anti-inflammatory, analgesic, and antispasmodic properties. However, it is important to note that the use of these plants for medicinal purposes should be done under the guidance of a qualified healthcare professional, as they can also contain toxic compounds that may cause adverse reactions in some individuals.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

Soft tissue infections are medical conditions that involve infection of the soft tissues of the body, which include the skin, muscles, fascia (the connective tissue that surrounds muscles), and tendons. These infections can be caused by various types of bacteria, viruses, fungi, or parasites.

Soft tissue infections can range from mild to severe, depending on the type of organism causing the infection, the extent of tissue involvement, and the patient's overall health status. Some common types of soft tissue infections include:

1. Cellulitis: This is a bacterial infection that affects the skin and underlying tissues. It typically presents as a red, swollen, warm, and painful area on the skin, often accompanied by fever and chills.
2. Abscess: An abscess is a localized collection of pus in the soft tissues, caused by an infection. It can appear as a swollen, tender, and warm lump under the skin, which may be filled with pus.
3. Necrotizing fasciitis: This is a rare but severe soft tissue infection that involves the rapid destruction of fascia and surrounding tissues. It is often caused by a mixture of bacteria and can progress rapidly, leading to shock, organ failure, and even death if not treated promptly.
4. Myositis: This is an inflammation of the muscle tissue, which can be caused by a bacterial or viral infection. Symptoms may include muscle pain, swelling, weakness, and fever.
5. Erysipelas: This is a superficial skin infection that affects the upper layers of the skin and the lymphatic vessels. It typically presents as a raised, red, and painful rash with clear borders.

Treatment for soft tissue infections depends on the type and severity of the infection but may include antibiotics, drainage of pus or abscesses, and surgery in severe cases. Preventive measures such as good hygiene, wound care, and prompt treatment of injuries can help reduce the risk of developing soft tissue infections.

Bacterial toxins are poisonous substances produced and released by bacteria. They can cause damage to the host organism's cells and tissues, leading to illness or disease. Bacterial toxins can be classified into two main types: exotoxins and endotoxins.

Exotoxins are proteins secreted by bacterial cells that can cause harm to the host. They often target specific cellular components or pathways, leading to tissue damage and inflammation. Some examples of exotoxins include botulinum toxin produced by Clostridium botulinum, which causes botulism; diphtheria toxin produced by Corynebacterium diphtheriae, which causes diphtheria; and tetanus toxin produced by Clostridium tetani, which causes tetanus.

Endotoxins, on the other hand, are components of the bacterial cell wall that are released when the bacteria die or divide. They consist of lipopolysaccharides (LPS) and can cause a generalized inflammatory response in the host. Endotoxins can be found in gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa.

Bacterial toxins can cause a wide range of symptoms depending on the type of toxin, the dose, and the site of infection. They can lead to serious illnesses or even death if left untreated. Vaccines and antibiotics are often used to prevent or treat bacterial infections and reduce the risk of severe complications from bacterial toxins.

Bacterial typing techniques are methods used to identify and differentiate bacterial strains or isolates based on their unique characteristics. These techniques are essential in epidemiological studies, infection control, and research to understand the transmission dynamics, virulence, and antibiotic resistance patterns of bacterial pathogens.

There are various bacterial typing techniques available, including:

1. **Bacteriophage Typing:** This method involves using bacteriophages (viruses that infect bacteria) to identify specific bacterial strains based on their susceptibility or resistance to particular phages.
2. **Serotyping:** It is a technique that differentiates bacterial strains based on the antigenic properties of their cell surface components, such as capsules, flagella, and somatic (O) and flagellar (H) antigens.
3. **Biochemical Testing:** This method uses biochemical reactions to identify specific metabolic pathways or enzymes present in bacterial strains, which can be used for differentiation. Commonly used tests include the catalase test, oxidase test, and various sugar fermentation tests.
4. **Molecular Typing Techniques:** These methods use genetic markers to identify and differentiate bacterial strains at the DNA level. Examples of molecular typing techniques include:
* **Pulsed-Field Gel Electrophoresis (PFGE):** This method uses restriction enzymes to digest bacterial DNA, followed by electrophoresis in an agarose gel under pulsed electrical fields. The resulting banding patterns are analyzed and compared to identify related strains.
* **Multilocus Sequence Typing (MLST):** It involves sequencing specific housekeeping genes to generate unique sequence types that can be used for strain identification and phylogenetic analysis.
* **Whole Genome Sequencing (WGS):** This method sequences the entire genome of a bacterial strain, providing the most detailed information on genetic variation and relatedness between strains. WGS data can be analyzed using various bioinformatics tools to identify single nucleotide polymorphisms (SNPs), gene deletions or insertions, and other genetic changes that can be used for strain differentiation.

These molecular typing techniques provide higher resolution than traditional methods, allowing for more accurate identification and comparison of bacterial strains. They are particularly useful in epidemiological investigations to track the spread of pathogens and identify outbreaks.

Nafcillin is a type of antibiotic known as a penicillinase-resistant penicillin. It is used to treat infections caused by bacteria that are resistant to other types of penicillins. Nafcillin is active against many gram-positive bacteria, including Staphylococcus aureus and Streptococcus pyogenes.

Nafcillin works by binding to and inhibiting the activity of certain proteins (called penicillin-binding proteins) that are necessary for the bacterial cell wall to synthesize properly. This leads to the death of the bacteria and the resolution of the infection.

Nafcillin is available in injectable form and is typically given intravenously (IV) in a hospital setting. It may also be given as an injection into a muscle (IM). The dosage and duration of treatment will depend on the type and severity of the infection being treated, as well as the patient's overall health and medical history.

It is important to note that nafcillin, like all antibiotics, should be used only to treat bacterial infections and not viral infections, such as the common cold or flu. Overuse of antibiotics can lead to the development of antibiotic resistance, which makes it more difficult to treat infections in the future.

A hospital is a healthcare facility where patients receive medical treatment, diagnosis, and care for various health conditions, injuries, or diseases. It is typically staffed with medical professionals such as doctors, nurses, and other healthcare workers who provide round-the-clock medical services. Hospitals may offer inpatient (overnight) stays or outpatient (same-day) services, depending on the nature of the treatment required. They are equipped with various medical facilities like operating rooms, diagnostic equipment, intensive care units (ICUs), and emergency departments to handle a wide range of medical situations. Hospitals may specialize in specific areas of medicine, such as pediatrics, geriatrics, oncology, or trauma care.

Bacteria are single-celled microorganisms that are among the earliest known life forms on Earth. They are typically characterized as having a cell wall and no membrane-bound organelles. The majority of bacteria have a prokaryotic organization, meaning they lack a nucleus and other membrane-bound organelles.

Bacteria exist in diverse environments and can be found in every habitat on Earth, including soil, water, and the bodies of plants and animals. Some bacteria are beneficial to their hosts, while others can cause disease. Beneficial bacteria play important roles in processes such as digestion, nitrogen fixation, and biogeochemical cycling.

Bacteria reproduce asexually through binary fission or budding, and some species can also exchange genetic material through conjugation. They have a wide range of metabolic capabilities, with many using organic compounds as their source of energy, while others are capable of photosynthesis or chemosynthesis.

Bacteria are highly adaptable and can evolve rapidly in response to environmental changes. This has led to the development of antibiotic resistance in some species, which poses a significant public health challenge. Understanding the biology and behavior of bacteria is essential for developing strategies to prevent and treat bacterial infections and diseases.

Gentamicin is an antibiotic that belongs to the class of aminoglycosides. It is used to treat various types of bacterial infections, including:

* Gram-negative bacterial infections, such as those caused by Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis
* Certain Gram-positive bacterial infections, such as those caused by Staphylococcus aureus and Streptococcus pyogenes

Gentamicin works by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death. It is typically given via injection (intramuscularly or intravenously) and is often used in combination with other antibiotics to treat serious infections.

Like all aminoglycosides, gentamicin can cause kidney damage and hearing loss, especially when used for long periods of time or at high doses. Therefore, monitoring of drug levels and renal function is recommended during treatment.

Staphylococcal Protein A (SpA) is a cell wall-associated protein found on many strains of the bacterium Staphylococcus aureus. It plays an important role in the pathogenesis of staphylococcal infections. SpA has several domains that allow it to bind to various host proteins, including immunoglobulins (Igs), complement components, and fibrinogen.

The protein A's ability to bind to the Fc region of Igs, particularly IgG, enables it to inhibit phagocytosis by masking the antibodies' binding sites, thus helping the bacterium evade the host immune system. Additionally, SpA can activate complement component C1 and initiate the classical complement pathway, leading to the release of anaphylatoxins and the formation of the membrane attack complex, which can cause tissue damage.

Furthermore, SpA's binding to fibrinogen promotes bacterial adherence and colonization of host tissues, contributing to the establishment of infection. Overall, Staphylococcal Protein A is a crucial virulence factor in S. aureus infections, making it an important target for the development of novel therapeutic strategies.

Bacteremia is the presence of bacteria in the bloodstream. It is a medical condition that occurs when bacteria from another source, such as an infection in another part of the body, enter the bloodstream. Bacteremia can cause symptoms such as fever, chills, and rapid heart rate, and it can lead to serious complications such as sepsis if not treated promptly with antibiotics.

Bacteremia is often a result of an infection elsewhere in the body that allows bacteria to enter the bloodstream. This can happen through various routes, such as during medical procedures, intravenous (IV) drug use, or from infected wounds or devices that come into contact with the bloodstream. In some cases, bacteremia may also occur without any obvious source of infection.

It is important to note that not all bacteria in the bloodstream cause harm, and some people may have bacteria in their blood without showing any symptoms. However, if bacteria in the bloodstream multiply and cause an immune response, it can lead to bacteremia and potentially serious complications.

Staphylococcus haemolyticus is a type of coagulase-negative staphylococci (CoNS) that is commonly found on the skin and mucous membranes of humans and animals. It is a gram-positive, facultatively anaerobic coccus that tends to form clusters resembling grapes when viewed under a microscope.

The term "haemolyticus" in its name refers to its ability to lyse red blood cells and cause hemolysis on blood agar media. However, not all strains of S. haemolyticus are necessarily hemolytic.

While S. haemolyticus is less virulent than Staphylococcus aureus, it can still cause infections, particularly in individuals with compromised immune systems or in healthcare settings. It has been associated with various types of infections, including bacteremia, endocarditis, urinary tract infections, and device-related infections such as catheter-associated infections.

Accurate identification of S. haemolyticus is important for appropriate antimicrobial therapy and infection control measures, as it may exhibit resistance to certain antibiotics commonly used to treat staphylococcal infections.

Quinolones are a class of antibacterial agents that are widely used in medicine to treat various types of infections caused by susceptible bacteria. These synthetic drugs contain a chemical structure related to quinoline and have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Quinolones work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, and repair.

The first quinolone antibiotic was nalidixic acid, discovered in 1962. Since then, several generations of quinolones have been developed, with each generation having improved antibacterial activity and a broader spectrum of action compared to the previous one. The various generations of quinolones include:

1. First-generation quinolones (e.g., nalidixic acid): Primarily used for treating urinary tract infections caused by Gram-negative bacteria.
2. Second-generation quinolones (e.g., ciprofloxacin, ofloxacin, norfloxacin): These drugs have improved activity against both Gram-positive and Gram-negative bacteria and are used to treat a wider range of infections, including respiratory, gastrointestinal, and skin infections.
3. Third-generation quinolones (e.g., levofloxacin, sparfloxacin, grepafloxacin): These drugs have enhanced activity against Gram-positive bacteria, including some anaerobes and atypical organisms like Legionella and Mycoplasma species.
4. Fourth-generation quinolones (e.g., moxifloxacin, gatifloxacin): These drugs have the broadest spectrum of activity, including enhanced activity against Gram-positive bacteria, anaerobes, and some methicillin-resistant Staphylococcus aureus (MRSA) strains.

Quinolones are generally well-tolerated, but like all medications, they can have side effects. Common adverse reactions include gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, and dizziness. Serious side effects, such as tendinitis, tendon rupture, peripheral neuropathy, and QT interval prolongation, are less common but can occur, particularly in older patients or those with underlying medical conditions. The use of quinolones should be avoided or used cautiously in these populations.

Quinolone resistance has become an increasing concern due to the widespread use of these antibiotics. Bacteria can develop resistance through various mechanisms, including chromosomal mutations and the acquisition of plasmid-mediated quinolone resistance genes. The overuse and misuse of quinolones contribute to the emergence and spread of resistant strains, which can limit treatment options for severe infections caused by these bacteria. Therefore, it is essential to use quinolones judiciously and only when clinically indicated, to help preserve their effectiveness and prevent further resistance development.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

Virulence factors are characteristics or components of a microorganism, such as bacteria, viruses, fungi, or parasites, that contribute to its ability to cause damage or disease in a host organism. These factors can include various structures, enzymes, or toxins that allow the pathogen to evade the host's immune system, attach to and invade host tissues, obtain nutrients from the host, or damage host cells directly.

Examples of virulence factors in bacteria include:

1. Endotoxins: lipopolysaccharides found in the outer membrane of Gram-negative bacteria that can trigger a strong immune response and inflammation.
2. Exotoxins: proteins secreted by some bacteria that have toxic effects on host cells, such as botulinum toxin produced by Clostridium botulinum or diphtheria toxin produced by Corynebacterium diphtheriae.
3. Adhesins: structures that help the bacterium attach to host tissues, such as fimbriae or pili in Escherichia coli.
4. Capsules: thick layers of polysaccharides or proteins that surround some bacteria and protect them from the host's immune system, like those found in Streptococcus pneumoniae or Klebsiella pneumoniae.
5. Invasins: proteins that enable bacteria to invade and enter host cells, such as internalins in Listeria monocytogenes.
6. Enzymes: proteins that help bacteria obtain nutrients from the host by breaking down various molecules, like hemolysins that lyse red blood cells to release iron or hyaluronidases that degrade connective tissue.

Understanding virulence factors is crucial for developing effective strategies to prevent and treat infectious diseases caused by these microorganisms.

Fluoroquinolones are a class of antibiotics that are widely used to treat various types of bacterial infections. They work by interfering with the bacteria's ability to replicate its DNA, which ultimately leads to the death of the bacterial cells. Fluoroquinolones are known for their broad-spectrum activity against both gram-positive and gram-negative bacteria.

Some common fluoroquinolones include ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin. These antibiotics are often used to treat respiratory infections, urinary tract infections, skin infections, and gastrointestinal infections, among others.

While fluoroquinolones are generally well-tolerated, they can cause serious side effects in some people, including tendonitis, nerve damage, and changes in mood or behavior. As with all antibiotics, it's important to use fluoroquinolones only when necessary and under the guidance of a healthcare provider.

Bacteriological techniques refer to the various methods and procedures used in the laboratory for the cultivation, identification, and study of bacteria. These techniques are essential in fields such as medicine, biotechnology, and research. Here are some common bacteriological techniques:

1. **Sterilization**: This is a process that eliminates or kills all forms of life, including bacteria, viruses, fungi, and spores. Common sterilization methods include autoclaving (using steam under pressure), dry heat (in an oven), chemical sterilants, and radiation.

2. **Aseptic Technique**: This refers to practices used to prevent contamination of sterile materials or environments with microorganisms. It includes the use of sterile equipment, gloves, and lab coats, as well as techniques such as flaming, alcohol swabbing, and using aseptic transfer devices.

3. **Media Preparation**: This involves the preparation of nutrient-rich substances that support bacterial growth. There are various types of media, including solid (agar), liquid (broth), and semi-solid (e.g., stab agar). The choice of medium depends on the type of bacteria being cultured and the purpose of the investigation.

4. **Inoculation**: This is the process of introducing a bacterial culture into a medium. It can be done using a loop, swab, or needle. The inoculum should be taken from a pure culture to avoid contamination.

5. **Incubation**: After inoculation, the bacteria are allowed to grow under controlled conditions of temperature, humidity, and atmospheric composition. This process is called incubation.

6. **Staining and Microscopy**: Bacteria are too small to be seen with the naked eye. Therefore, they need to be stained and observed under a microscope. Gram staining is a common method used to differentiate between two major groups of bacteria based on their cell wall composition.

7. **Biochemical Tests**: These are tests used to identify specific bacterial species based on their biochemical characteristics, such as their ability to ferment certain sugars, produce particular enzymes, or resist certain antibiotics.

8. **Molecular Techniques**: Advanced techniques like PCR and DNA sequencing can provide more precise identification of bacteria. They can also be used for genetic analysis and epidemiological studies.

Remember, handling microorganisms requires careful attention to biosafety procedures to prevent accidental infection or environmental contamination.

Culture media is a substance that is used to support the growth of microorganisms or cells in an artificial environment, such as a petri dish or test tube. It typically contains nutrients and other factors that are necessary for the growth and survival of the organisms being cultured. There are many different types of culture media, each with its own specific formulation and intended use. Some common examples include blood agar, which is used to culture bacteria; Sabouraud dextrose agar, which is used to culture fungi; and Eagle's minimum essential medium, which is used to culture animal cells.

Bacterial endocarditis is a medical condition characterized by the inflammation and infection of the inner layer of the heart, known as the endocardium. This infection typically occurs when bacteria enter the bloodstream and attach themselves to damaged or abnormal heart valves or other parts of the endocardium. The bacteria can then multiply and cause the formation of vegetations, which are clusters of infected tissue that can further damage the heart valves and lead to serious complications such as heart failure, stroke, or even death if left untreated.

Bacterial endocarditis is a relatively uncommon but potentially life-threatening condition that requires prompt medical attention. Risk factors for developing bacterial endocarditis include pre-existing heart conditions such as congenital heart defects, artificial heart valves, previous history of endocarditis, or other conditions that damage the heart valves. Intravenous drug use is also a significant risk factor for this condition.

Symptoms of bacterial endocarditis may include fever, chills, fatigue, muscle and joint pain, shortness of breath, chest pain, and a new or changing heart murmur. Diagnosis typically involves a combination of medical history, physical examination, blood cultures, and imaging tests such as echocardiography. Treatment usually involves several weeks of intravenous antibiotics to eradicate the infection, and in some cases, surgical intervention may be necessary to repair or replace damaged heart valves.

Penicillin-Binding Proteins (PBPs) are essential bacterial enzymes that play a crucial role in the synthesis and maintenance of the bacterial cell wall. They are called "penicillin-binding" because they possess the ability to bind to penicillin and other beta-lactam antibiotics, which subsequently inhibits their function and leads to the death of the bacteria. PBPs are primary targets for many clinically important antibiotics, including penicillins, cephalosporins, and carbapenems. Inhibition of these proteins interferes with the cross-linking of peptidoglycan in the bacterial cell wall, causing structural weakness and osmotic lysis of the bacteria.

Rifampin is an antibiotic medication that belongs to the class of drugs known as rifamycins. It works by inhibiting bacterial DNA-dependent RNA polymerase, thereby preventing bacterial growth and multiplication. Rifampin is used to treat a variety of infections caused by bacteria, including tuberculosis, Haemophilus influenzae, Neisseria meningitidis, and Legionella pneumophila. It is also used to prevent meningococcal disease in people who have been exposed to the bacteria.

Rifampin is available in various forms, including tablets, capsules, and injectable solutions. The medication is usually taken two to four times a day, depending on the type and severity of the infection being treated. Rifampin may be given alone or in combination with other antibiotics.

It is important to note that rifampin can interact with several other medications, including oral contraceptives, anticoagulants, and anti-seizure drugs, among others. Therefore, it is essential to inform your healthcare provider about all the medications you are taking before starting treatment with rifampin.

Rifampin may cause side effects such as nausea, vomiting, diarrhea, dizziness, headache, and changes in the color of urine, tears, sweat, and saliva to a reddish-orange color. These side effects are usually mild and go away on their own. However, if they persist or become bothersome, it is important to consult your healthcare provider.

In summary, rifampin is an antibiotic medication used to treat various bacterial infections and prevent meningococcal disease. It works by inhibiting bacterial DNA-dependent RNA polymerase, preventing bacterial growth and multiplication. Rifampin may interact with several other medications, and it can cause side effects such as nausea, vomiting, diarrhea, dizziness, headache, and changes in the color of body fluids.

Lysostaphin is not a disease or condition, but rather a bacteriolytic enzyme produced by certain strains of Staphylococcus species. It is an endopeptidase that specifically targets and cleaves the pentaglycine cross-bridge in the cell wall peptidoglycan of Staphylococcus aureus, leading to bacterial lysis and death. Lysostaphin has been studied for its potential therapeutic use in treating Staphylococcus aureus infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) strains.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

Muramoylpentapeptide Carboxypeptidase is not a commonly used medical term, but it refers to an enzyme involved in the bacterial cell wall biosynthesis and degradation process. The muramoylpentapeptide is a component of the bacterial cell wall peptidoglycan. Carboxypeptidases are enzymes that cleave peptide bonds, specifically at the carboxyl-terminal end of a protein or peptide.

In this context, Muramoylpentapeptide Carboxypeptidase is an enzyme that removes the terminal D-alanine residue from the muramoylpentapeptide, which is a crucial step in the biosynthesis and recycling of bacterial cell wall components. This enzyme plays a significant role in the regulation of peptidoglycan structure and thus impacts bacterial growth, division, and virulence.

Inhibition or disruption of Muramoylpentapeptide Carboxypeptidase can potentially be used as an antibacterial strategy, targeting essential processes in bacterial cell wall biosynthesis and weakening the structural integrity of pathogenic bacteria.

Hexosyltransferases are a group of enzymes that catalyze the transfer of a hexose (a type of sugar molecule made up of six carbon atoms) from a donor molecule to an acceptor molecule. This transfer results in the formation of a glycosidic bond between the two molecules.

Hexosyltransferases are involved in various biological processes, including the biosynthesis of complex carbohydrates, such as glycoproteins and glycolipids, which play important roles in cell recognition, signaling, and communication. These enzymes can transfer a variety of hexose sugars, including glucose, galactose, mannose, fucose, and N-acetylglucosamine, to different acceptor molecules, such as proteins, lipids, or other carbohydrates.

Hexosyltransferases are classified based on the type of donor molecule they use, the type of sugar they transfer, and the type of glycosidic bond they form. Some examples of hexosyltransferases include:

* Glycosyltransferases (GTs): These enzymes transfer a sugar from an activated donor molecule, such as a nucleotide sugar, to an acceptor molecule. GTs are involved in the biosynthesis of various glycoconjugates, including proteoglycans, glycoproteins, and glycolipids.
* Fucosyltransferases (FUTs): These enzymes transfer fucose, a type of hexose sugar, to an acceptor molecule. FUTs are involved in the biosynthesis of various glycoconjugates, including blood group antigens and Lewis antigens.
* Galactosyltransferases (GALTs): These enzymes transfer galactose, another type of hexose sugar, to an acceptor molecule. GALTs are involved in the biosynthesis of various glycoconjugates, including lactose in milk and gangliosides in the brain.
* Mannosyltransferases (MTs): These enzymes transfer mannose, a type of hexose sugar, to an acceptor molecule. MTs are involved in the biosynthesis of various glycoconjugates, including N-linked glycoproteins and yeast cell walls.

Hexosyltransferases play important roles in many biological processes, including cell recognition, signaling, and adhesion. Dysregulation of these enzymes has been implicated in various diseases, such as cancer, inflammation, and neurodegenerative disorders. Therefore, understanding the mechanisms of hexosyltransferases is crucial for developing new therapeutic strategies.

Penicillins are a group of antibiotics derived from the Penicillium fungus. They are widely used to treat various bacterial infections due to their bactericidal activity, which means they kill bacteria by interfering with the synthesis of their cell walls. The first penicillin, benzylpenicillin (also known as penicillin G), was discovered in 1928 by Sir Alexander Fleming. Since then, numerous semi-synthetic penicillins have been developed to expand the spectrum of activity and stability against bacterial enzymes that can inactivate these drugs.

Penicillins are classified into several groups based on their chemical structure and spectrum of activity:

1. Natural Penicillins (e.g., benzylpenicillin, phenoxymethylpenicillin): These have a narrow spectrum of activity, mainly targeting Gram-positive bacteria such as streptococci and staphylococci. However, they are susceptible to degradation by beta-lactamase enzymes produced by some bacteria.
2. Penicillinase-resistant Penicillins (e.g., methicillin, oxacillin, nafcillin): These penicillins resist degradation by certain bacterial beta-lactamases and are primarily used to treat infections caused by staphylococci, including methicillin-susceptible Staphylococcus aureus (MSSA).
3. Aminopenicillins (e.g., ampicillin, amoxicillin): These penicillins have an extended spectrum of activity compared to natural penicillins, including some Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae. However, they are still susceptible to degradation by many beta-lactamases.
4. Antipseudomonal Penicillins (e.g., carbenicillin, ticarcillin): These penicillins have activity against Pseudomonas aeruginosa and other Gram-negative bacteria with increased resistance to other antibiotics. They are often combined with beta-lactamase inhibitors such as clavulanate or tazobactam to protect them from degradation.
5. Extended-spectrum Penicillins (e.g., piperacillin): These penicillins have a broad spectrum of activity, including many Gram-positive and Gram-negative bacteria. They are often combined with beta-lactamase inhibitors to protect them from degradation.

Penicillins are generally well-tolerated antibiotics; however, they can cause allergic reactions in some individuals, ranging from mild skin rashes to life-threatening anaphylaxis. Cross-reactivity between different penicillin classes and other beta-lactam antibiotics (e.g., cephalosporins) is possible but varies depending on the specific drugs involved.

Peptidyl transferase is not a medical term per se, but rather a biochemical term used to describe an enzymatic function or activity. It is often mentioned in the context of molecular biology, protein synthesis, and ribosome structure.

Peptidyl transferase refers to the catalytic activity of ribosomes that facilitates the formation of peptide bonds between amino acids during protein synthesis. More specifically, peptidyl transferase is responsible for transferring the peptidyl group (the growing polypeptide chain) from the acceptor site (A-site) to the donor site (P-site) of the ribosome, creating a new peptide bond and elongating the polypeptide chain. This activity occurs within the large subunit of the ribosome, near the peptidyl transferase center (PTC).

While it is often attributed to the ribosomal RNA (rRNA) component of the ribosome, recent research suggests that both rRNA and specific ribosomal proteins contribute to this enzymatic activity.

A "colony count" is a method used to estimate the number of viable microorganisms, such as bacteria or fungi, in a sample. In this technique, a known volume of the sample is spread onto the surface of a solid nutrient medium in a petri dish and then incubated under conditions that allow the microorganisms to grow and form visible colonies. Each colony that grows on the plate represents an individual cell (or small cluster of cells) from the original sample that was able to divide and grow under the given conditions. By counting the number of colonies that form, researchers can make a rough estimate of the concentration of microorganisms in the original sample.

The term "microbial" simply refers to microscopic organisms, such as bacteria, fungi, or viruses. Therefore, a "colony count, microbial" is a general term that encompasses the use of colony counting techniques to estimate the number of any type of microorganism in a sample.

Colony counts are used in various fields, including medical research, food safety testing, and environmental monitoring, to assess the levels of contamination or the effectiveness of disinfection procedures. However, it is important to note that colony counts may not always provide an accurate measure of the total number of microorganisms present in a sample, as some cells may be injured or unable to grow under the conditions used for counting. Additionally, some microorganisms may form clusters or chains that can appear as single colonies, leading to an overestimation of the true cell count.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Virginiamycin is not a medical condition or disease, but rather an antibiotic used in veterinary medicine to promote growth and prevent or treat certain bacterial infections in animals, particularly in livestock such as cattle, swine, and poultry. It is a mixture of two components, virginiamycin M1 and virginiamycin S1, which have antibacterial properties against gram-positive bacteria.

Virginiamycin belongs to the streptogramin class of antibiotics and works by binding to the bacterial ribosome, inhibiting protein synthesis and ultimately killing the bacteria. It is not approved for use in humans, except under certain circumstances as part of an investigational new drug (IND) protocol or in specific medical devices.

It's important to note that the use of antibiotics in livestock can contribute to the development of antibiotic-resistant bacteria, which can have negative impacts on human health. Therefore, responsible and judicious use of antibiotics is essential to minimize this risk.

Mupirocin is a topical antibiotic medication used to treat infections caused by bacteria. Its medical definition, according to the National Library of Medicine (NLM), is: "A topical antimicrobial agent that is used to eradicate staphylococcal and streptococcal bacteria from the nose and skin. It is also used as a first-line treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections."

Mupirocin works by inhibiting protein synthesis in bacteria, which prevents them from multiplying. This topical antibiotic is available as an ointment or cream and is usually applied three times a day for 5 to 10 days. It is important to note that mupirocin should only be used to treat bacterial infections and not viral or fungal infections, as it has no effect on these types of pathogens.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

Staphylococcal pneumonia is a type of pneumonia caused by the bacterium Staphylococcus aureus. This bacteria can colonize the upper respiratory tract and sometimes invade the lower respiratory tract, causing pneumonia.

The symptoms of staphylococcal pneumonia are often severe and may include fever, cough, chest pain, shortness of breath, and production of purulent sputum. The disease can progress rapidly, leading to complications such as pleural effusion (accumulation of fluid in the space surrounding the lungs), empyema (pus in the pleural space), and bacteremia (bacteria in the bloodstream).

Staphylococcal pneumonia can occur in otherwise healthy individuals, but it is more common in people with underlying medical conditions such as chronic lung disease, diabetes, or a weakened immune system. It can also occur in healthcare settings, where S. aureus may be transmitted from person to person or through contaminated equipment.

Treatment of staphylococcal pneumonia typically involves the use of antibiotics that are active against S. aureus, such as nafcillin or vancomycin. In some cases, surgery may be necessary to drain fluid from the pleural space.

Penicillinase is an enzyme produced by some bacteria that can inactivate penicillin and other beta-lactam antibiotics by breaking down the beta-lactam ring, which is essential for their antimicrobial activity. Bacteria that produce penicillinase are resistant to penicillin and related antibiotics. Penicillinase-resistant penicillins, such as methicillin and oxacillin, have been developed to overcome this form of bacterial resistance.

Cloxacillin is a type of antibiotic known as a penicillinase-resistant penicillin. It is used to treat infections caused by bacteria that are resistant to other types of penicillins. Cloxacillin works by interfering with the ability of the bacterial cell wall to grow and multiply, ultimately leading to the death of the bacterium.

Cloxacillin is often used to treat skin infections, pneumonia, and other respiratory tract infections. It is available in various forms, including tablets, capsules, and powder for injection. As with all antibiotics, it is important to take cloxacillin exactly as directed by a healthcare provider, and to complete the full course of treatment, even if symptoms improve before all of the medication has been taken.

Like other penicillins, cloxacillin can cause allergic reactions in some people. It may also interact with other medications, so it is important to inform a healthcare provider of all other medications being taken before starting cloxacillin.

A plant extract is a preparation containing chemical constituents that have been extracted from a plant using a solvent. The resulting extract may contain a single compound or a mixture of several compounds, depending on the extraction process and the specific plant material used. These extracts are often used in various industries including pharmaceuticals, nutraceuticals, cosmetics, and food and beverage, due to their potential therapeutic or beneficial properties. The composition of plant extracts can vary widely, and it is important to ensure their quality, safety, and efficacy before use in any application.

Bacteriophage typing is a laboratory method used to identify and differentiate bacterial strains based on their susceptibility to specific bacteriophages, which are viruses that infect and replicate within bacteria. In this technique, a standard set of bacteriophages with known host ranges are allowed to infect and form plaques on a lawn of bacterial cells grown on a solid medium, such as agar. The pattern and number of plaques formed are then used to identify the specific bacteriophage types that are able to infect the bacterial strain, providing a unique "fingerprint" or profile that can be used for typing and differentiating different bacterial strains.

Bacteriophage typing is particularly useful in epidemiological studies, as it can help track the spread of specific bacterial clones within a population, monitor antibiotic resistance patterns, and provide insights into the evolution and ecology of bacterial pathogens. It has been widely used in the study of various bacterial species, including Staphylococcus aureus, Salmonella enterica, and Mycobacterium tuberculosis, among others.

DNA fingerprinting, also known as DNA profiling or genetic fingerprinting, is a laboratory technique used to identify and compare the unique genetic makeup of individuals by analyzing specific regions of their DNA. This method is based on the variation in the length of repetitive sequences of DNA called variable number tandem repeats (VNTRs) or short tandem repeats (STRs), which are located at specific locations in the human genome and differ significantly among individuals, except in the case of identical twins.

The process of DNA fingerprinting involves extracting DNA from a sample, amplifying targeted regions using the polymerase chain reaction (PCR), and then separating and visualizing the resulting DNA fragments through electrophoresis. The fragment patterns are then compared to determine the likelihood of a match between two samples.

DNA fingerprinting has numerous applications in forensic science, paternity testing, identity verification, and genealogical research. It is considered an essential tool for providing strong evidence in criminal investigations and resolving disputes related to parentage and inheritance.

Enterococcus is a genus of gram-positive, facultatively anaerobic bacteria that are commonly found in the intestinal tracts of humans and animals. They are part of the normal gut microbiota but can also cause a variety of infections, particularly in hospital settings. Enterococci are known for their ability to survive in harsh environments and can be resistant to many antibiotics, making them difficult to treat. Some species, such as Enterococcus faecalis and Enterococcus faecium, are more commonly associated with human infections.

In medical terms, an "Enterococcus infection" refers to an infection caused by any species of the Enterococcus genus. These infections can occur in various parts of the body, including the urinary tract, bloodstream, and abdominal cavity. They can cause symptoms such as fever, chills, and pain, depending on the location of the infection. Treatment typically involves the use of antibiotics that are effective against Enterococcus species, although resistance to multiple antibiotics is a growing concern.

Tetracycline is a broad-spectrum antibiotic, which is used to treat various bacterial infections. It works by preventing the growth and multiplication of bacteria. It is a part of the tetracycline class of antibiotics, which also includes doxycycline, minocycline, and others.

Tetracycline is effective against a wide range of gram-positive and gram-negative bacteria, as well as some atypical organisms such as rickettsia, chlamydia, mycoplasma, and spirochetes. It is commonly used to treat respiratory infections, skin infections, urinary tract infections, sexually transmitted diseases, and other bacterial infections.

Tetracycline is available in various forms, including tablets, capsules, and liquid solutions. It should be taken orally with a full glass of water, and it is recommended to take it on an empty stomach, at least one hour before or two hours after meals. The drug can cause tooth discoloration in children under the age of 8, so it is generally not recommended for use in this population.

Like all antibiotics, tetracycline should be used only to treat bacterial infections and not viral infections, such as the common cold or flu. Overuse or misuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

Cephalosporins are a class of antibiotics that are derived from the fungus Acremonium, originally isolated from seawater and cow dung. They have a similar chemical structure to penicillin and share a common four-membered beta-lactam ring in their molecular structure.

Cephalosporins work by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. They are broad-spectrum antibiotics, meaning they are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

There are several generations of cephalosporins, each with different spectra of activity and pharmacokinetic properties. The first generation cephalosporins have a narrow spectrum of activity and are primarily used to treat infections caused by susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae.

Second-generation cephalosporins have an expanded spectrum of activity that includes some Gram-negative organisms, such as Escherichia coli and Haemophilus influenzae. Third-generation cephalosporins have even broader spectra of activity and are effective against many resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae.

Fourth-generation cephalosporins have activity against both Gram-positive and Gram-negative organisms, including some that are resistant to other antibiotics. They are often reserved for the treatment of serious infections caused by multidrug-resistant bacteria.

Cephalosporins are generally well tolerated, but like penicillin, they can cause allergic reactions in some individuals. Cross-reactivity between cephalosporins and penicillin is estimated to occur in 5-10% of patients with a history of penicillin allergy. Other potential adverse effects include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), neurotoxicity, and nephrotoxicity.

Bacterial infections are caused by the invasion and multiplication of bacteria in or on tissues of the body. These infections can range from mild, like a common cold, to severe, such as pneumonia, meningitis, or sepsis. The symptoms of a bacterial infection depend on the type of bacteria invading the body and the area of the body that is affected.

Bacteria are single-celled microorganisms that can live in many different environments, including in the human body. While some bacteria are beneficial to humans and help with digestion or protect against harmful pathogens, others can cause illness and disease. When bacteria invade the body, they can release toxins and other harmful substances that damage tissues and trigger an immune response.

Bacterial infections can be treated with antibiotics, which work by killing or inhibiting the growth of bacteria. However, it is important to note that misuse or overuse of antibiotics can lead to antibiotic resistance, making treatment more difficult. It is also essential to complete the full course of antibiotics as prescribed, even if symptoms improve, to ensure that all bacteria are eliminated and reduce the risk of recurrence or development of antibiotic resistance.

The nasal cavity is the air-filled space located behind the nose, which is divided into two halves by the nasal septum. It is lined with mucous membrane and is responsible for several functions including respiration, filtration, humidification, and olfaction (smell). The nasal cavity serves as an important part of the upper respiratory tract, extending from the nares (nostrils) to the choanae (posterior openings of the nasal cavity that lead into the pharynx). It contains specialized structures such as turbinate bones, which help to warm, humidify and filter incoming air.

Biofilms are defined as complex communities of microorganisms, such as bacteria and fungi, that adhere to surfaces and are enclosed in a matrix made up of extracellular polymeric substances (EPS). The EPS matrix is composed of polysaccharides, proteins, DNA, and other molecules that provide structural support and protection to the microorganisms within.

Biofilms can form on both living and non-living surfaces, including medical devices, implants, and biological tissues. They are resistant to antibiotics, disinfectants, and host immune responses, making them difficult to eradicate and a significant cause of persistent infections. Biofilms have been implicated in a wide range of medical conditions, including chronic wounds, urinary tract infections, middle ear infections, and device-related infections.

The formation of biofilms typically involves several stages, including initial attachment, microcolony formation, maturation, and dispersion. Understanding the mechanisms underlying biofilm formation and development is crucial for developing effective strategies to prevent and treat biofilm-associated infections.

Molecular epidemiology is a branch of epidemiology that uses laboratory techniques to identify and analyze the genetic material (DNA, RNA) of pathogens or host cells to understand their distribution, transmission, and disease associations in populations. It combines molecular biology methods with epidemiological approaches to investigate the role of genetic factors in disease occurrence and outcomes. This field has contributed significantly to the identification of infectious disease outbreaks, tracking the spread of antibiotic-resistant bacteria, understanding the transmission dynamics of viruses, and identifying susceptible populations for targeted interventions.

Fusidic Acid is a steroid antibiotic, derived from the fungus Fusidium coccineum. It is primarily used to treat skin infections and other susceptible bacterial infections. It works by inhibiting bacterial protein synthesis. In medical terms, it can be defined as:

A triterpenoid antibiotic derived from the fungus Fusidium coccineum, used primarily to treat staphylococcal and streptococcal skin infections that are resistant to other antibiotics. It inhibits bacterial protein synthesis by binding to the bacterial elongation factor EF-G, preventing translocation of peptidyl tRNA from the A site to the P site on the ribosome.

It is important to note that resistance to fusidic acid can develop and its use should be reserved for infections caused by organisms known to be susceptible to it. It is not typically used as a first-line antibiotic, but rather as a secondary option when other treatments have failed or are contraindicated.

An abscess is a localized collection of pus caused by an infection. It is typically characterized by inflammation, redness, warmth, pain, and swelling in the affected area. Abscesses can form in various parts of the body, including the skin, teeth, lungs, brain, and abdominal organs. They are usually treated with antibiotics to eliminate the infection and may require drainage if they are large or located in a critical area. If left untreated, an abscess can lead to serious complications such as sepsis or organ failure.

Peptidoglycan is a complex biological polymer made up of sugars and amino acids that forms a crucial component of the cell walls of bacteria. It provides structural support and protection to bacterial cells, contributing to their shape and rigidity. Peptidoglycan is unique to bacterial cell walls and is not found in the cells of other organisms, such as plants, animals, or fungi.

The polymer is composed of linear chains of alternating units of N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM), which are linked together by glycosidic bonds. The NAM residues contain short peptide side chains, typically consisting of four amino acids, that cross-link adjacent polysaccharide chains, forming a rigid layer around the bacterial cell.

The composition and structure of peptidoglycan can vary between different species of bacteria, which is one factor contributing to their diversity. The enzymes responsible for synthesizing and degrading peptidoglycan are important targets for antibiotics, as inhibiting these processes can weaken or kill the bacterial cells without affecting host organisms.

A cell wall is a rigid layer found surrounding the plasma membrane of plant cells, fungi, and many types of bacteria. It provides structural support and protection to the cell, maintains cell shape, and acts as a barrier against external factors such as chemicals and mechanical stress. The composition of the cell wall varies among different species; for example, in plants, it is primarily made up of cellulose, hemicellulose, and pectin, while in bacteria, it is composed of peptidoglycan.

Bovine mastitis is a common inflammatory condition that affects the mammary gland (udder) of dairy cows. It's primarily caused by bacterial infections, with Escherichia coli (E. coli), Streptococcus spp., and Staphylococcus aureus being some of the most common pathogens involved. The infection can lead to varying degrees of inflammation, which might result in decreased milk production, changes in milk composition, and, if left untreated, potentially severe systemic illness in the cow.

The clinical signs of bovine mastitis may include:
- Redness and heat in the affected quarter (or quarters) of the udder
- Swelling and pain upon palpation
- Decreased milk production or changes in milk appearance (such as flakes, clots, or watery consistency)
- Systemic signs like fever, loss of appetite, and depression in severe cases

Mastitis can be classified into two main types: clinical mastitis, which is characterized by visible signs of inflammation, and subclinical mastitis, where the infection might not present with obvious external symptoms but could still lead to decreased milk quality and production.

Prevention and control measures for bovine mastitis include good milking practices, maintaining a clean and dry environment for the cows, practicing proper udder hygiene, administering antibiotics or other treatments as necessary, and regularly monitoring milk for signs of infection through somatic cell count testing.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

Ofloxacin is an antibacterial drug, specifically a fluoroquinolone. It works by inhibiting the bacterial DNA gyrase, which is essential for the bacteria to replicate. This results in the death of the bacteria and helps to stop the infection. Ofloxacin is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and sexually transmitted diseases. It is available in various forms, such as tablets, capsules, and eye drops. As with any medication, it should be used only under the direction of a healthcare professional, and its use may be associated with certain risks and side effects.

Staphylococcal vaccines are immunizations that are developed to protect against infections caused by the Staphylococcus bacteria, particularly Staphylococcus aureus. These vaccines typically contain components of the bacterial cell wall or toxins that stimulate an immune response in the body, leading to the production of antibodies that can recognize and neutralize the bacteria if they invade the body in the future.

There are currently no licensed staphylococcal vaccines available for use in humans, although several candidates are in various stages of development. These vaccines aim to prevent a range of staphylococcal infections, including skin and soft tissue infections, pneumonia, bloodstream infections, and toxic shock syndrome.

It's important to note that while antibiotics can be effective against staphylococcal infections, the bacteria have become increasingly resistant to these drugs over time, making vaccines an important area of research and development for preventing and controlling the spread of these infections.

Gene expression regulation in bacteria refers to the complex cellular processes that control the production of proteins from specific genes. This regulation allows bacteria to adapt to changing environmental conditions and ensure the appropriate amount of protein is produced at the right time.

Bacteria have a variety of mechanisms for regulating gene expression, including:

1. Operon structure: Many bacterial genes are organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule. The expression of these genes can be coordinately regulated by controlling the transcription of the entire operon.
2. Promoter regulation: Transcription is initiated at promoter regions upstream of the gene or operon. Bacteria have regulatory proteins called sigma factors that bind to the promoter and recruit RNA polymerase, the enzyme responsible for transcribing DNA into RNA. The binding of sigma factors can be influenced by environmental signals, allowing for regulation of transcription.
3. Attenuation: Some operons have regulatory regions called attenuators that control transcription termination. These regions contain hairpin structures that can form in the mRNA and cause transcription to stop prematurely. The formation of these hairpins is influenced by the concentration of specific metabolites, allowing for regulation of gene expression based on the availability of those metabolites.
4. Riboswitches: Some bacterial mRNAs contain regulatory elements called riboswitches that bind small molecules directly. When a small molecule binds to the riboswitch, it changes conformation and affects transcription or translation of the associated gene.
5. CRISPR-Cas systems: Bacteria use CRISPR-Cas systems for adaptive immunity against viruses and plasmids. These systems incorporate short sequences from foreign DNA into their own genome, which can then be used to recognize and cleave similar sequences in invading genetic elements.

Overall, gene expression regulation in bacteria is a complex process that allows them to respond quickly and efficiently to changing environmental conditions. Understanding these regulatory mechanisms can provide insights into bacterial physiology and help inform strategies for controlling bacterial growth and behavior.

Levofloxacin is an antibiotic medication that belongs to the fluoroquinolone class. It works by interfering with the bacterial DNA replication, transcription, and repair processes, leading to bacterial cell death. Levofloxacin is used to treat a variety of infections caused by susceptible bacteria, including respiratory, skin, urinary tract, and gastrointestinal infections. It is available in various forms, such as tablets, oral solution, and injection, for different routes of administration.

The medical definition of Levofloxacin can be stated as:

Levofloxacin is a synthetic antibacterial drug with the chemical name (-)-(S)-9-fluoro-2,3-dihydro-3-methoxy-10-(4-methyl-1-piperazinyl)-9-oxoanthracene-1-carboxylic acid l-alanyl-l-proline methylester monohydrate. It is the levo isomer of ofloxacin and is used to treat a wide range of bacterial infections by inhibiting bacterial DNA gyrase, thereby preventing DNA replication and transcription. Levofloxacin is available as tablets, oral solution, and injection for oral and parenteral administration.

Cefoxitin is a type of antibiotic known as a cephamycin, which is a subclass of the larger group of antibiotics called cephalosporins. Cephalosporins are bactericidal agents that inhibit bacterial cell wall synthesis by binding to and disrupting the function of penicillin-binding proteins (PBPs).

Cefoxitin has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including many strains that are resistant to other antibiotics. It is commonly used to treat infections caused by susceptible organisms such as:

* Staphylococcus aureus (including methicillin-resistant S. aureus or MRSA)
* Streptococcus pneumoniae
* Escherichia coli
* Klebsiella spp.
* Proteus mirabilis
* Bacteroides fragilis and other anaerobic bacteria

Cefoxitin is available in both intravenous (IV) and intramuscular (IM) formulations, and it is typically administered every 6 to 8 hours. The drug is generally well tolerated, but potential side effects include gastrointestinal symptoms such as diarrhea, nausea, and vomiting, as well as allergic reactions, including rash, pruritus, and anaphylaxis.

It's important to note that the use of antibiotics should be based on the results of bacterial cultures and susceptibility testing whenever possible, to ensure appropriate therapy and minimize the development of antibiotic resistance.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Enterotoxins are types of toxic substances that are produced by certain microorganisms, such as bacteria. These toxins are specifically designed to target and affect the cells in the intestines, leading to symptoms such as diarrhea, vomiting, and abdominal cramps. One well-known example of an enterotoxin is the toxin produced by Staphylococcus aureus bacteria, which can cause food poisoning. Another example is the cholera toxin produced by Vibrio cholerae, which can cause severe diarrhea and dehydration. Enterotoxins work by interfering with the normal functioning of intestinal cells, leading to fluid accumulation in the intestines and subsequent symptoms.

Bacteriolysis is the breaking down or destruction of bacterial cells. This process can occur naturally or as a result of medical treatment, such as when antibiotics target and destroy bacteria by disrupting their cell walls. The term "bacteriolysis" specifically refers to the breakdown of the bacterial cell membrane, which can lead to the release of the contents of the bacterial cell and ultimately result in the death of the organism.

I'm sorry for any confusion, but "Exfoliatins" is not a recognized medical term or a known medical condition. It seems like there might be a spelling mistake or a mix-up with the terminology. Exfoliation refers to the natural process of shedding dead skin cells from the surface of the skin. If you have any specific concerns about skin issues or other health problems, I would recommend consulting a healthcare professional for accurate information and advice tailored to your situation.

Osteomyelitis is a medical condition characterized by an infection that involves the bone or the bone marrow. It can occur as a result of a variety of factors, including bacterial or fungal infections that spread to the bone from another part of the body, or direct infection of the bone through trauma or surgery.

The symptoms of osteomyelitis may include pain and tenderness in the affected area, fever, chills, fatigue, and difficulty moving the affected limb. In some cases, there may also be redness, swelling, and drainage from the infected area. The diagnosis of osteomyelitis typically involves imaging tests such as X-rays, CT scans, or MRI scans, as well as blood tests and cultures to identify the underlying cause of the infection.

Treatment for osteomyelitis usually involves a combination of antibiotics or antifungal medications to eliminate the infection, as well as pain management and possibly surgical debridement to remove infected tissue. In severe cases, hospitalization may be necessary to monitor and manage the condition.

Cephalothin is a type of antibiotic known as a first-generation cephalosporin. It is used to treat a variety of bacterial infections, including respiratory tract infections, skin and soft tissue infections, bone and joint infections, and urinary tract infections.

Cephalothin works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. It binds to specific proteins in the bacterial cell wall, causing the wall to become unstable and ultimately leading to the death of the bacterium.

Like other antibiotics, cephalothin is only effective against certain types of bacteria, and it should be used under the direction of a healthcare professional. It is important to take the full course of treatment as directed, even if symptoms improve, to ensure that the infection is fully treated and to reduce the risk of developing antibiotic resistance.

Common side effects of cephalothin include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. More serious side effects may include allergic reactions, kidney damage, and seizures. It is important to inform your healthcare provider of any medical conditions you have or medications you are taking before starting treatment with cephalothin.

Teichoic acids are complex polymers of glycerol or ribitol linked by phosphate groups, found in the cell wall of gram-positive bacteria. They play a crucial role in the bacterial cell's defense against hostile environments and can also contribute to virulence by helping the bacteria evade the host's immune system. Teichoic acids can be either linked to peptidoglycan (wall teichoic acids) or to membrane lipids (lipoteichoic acids). They can vary in structure and composition among different bacterial species, which can have implications for the design of antibiotics and other therapeutics.

Gram-negative bacteria are a type of bacteria that do not retain the crystal violet stain used in the Gram staining method, a standard technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This method was developed by Hans Christian Gram in 1884.

The primary characteristic distinguishing Gram-negative bacteria from Gram-positive bacteria is the composition and structure of their cell walls:

1. Cell wall: Gram-negative bacteria have a thin peptidoglycan layer, making it more susceptible to damage and less rigid compared to Gram-positive bacteria.
2. Outer membrane: They possess an additional outer membrane that contains lipopolysaccharides (LPS), which are endotoxins that can trigger strong immune responses in humans and animals. The outer membrane also contains proteins, known as porins, which form channels for the passage of molecules into and out of the cell.
3. Periplasm: Between the inner and outer membranes lies a compartment called the periplasm, where various enzymes and other molecules are located.

Some examples of Gram-negative bacteria include Escherichia coli (E. coli), Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella enterica, Shigella spp., and Neisseria meningitidis. These bacteria are often associated with various infections, such as urinary tract infections, pneumonia, sepsis, and meningitis. Due to their complex cell wall structure, Gram-negative bacteria can be more resistant to certain antibiotics, making them a significant concern in healthcare settings.

Microbial viability is the ability of a microorganism to grow, reproduce and maintain its essential life functions. It can be determined through various methods such as cell growth in culture media, staining techniques that detect metabolic activity, or direct observation of active movement. In contrast, non-viable microorganisms are those that have been killed or inactivated and cannot replicate or cause further harm. The measurement of microbial viability is important in various fields such as medicine, food safety, water quality, and environmental monitoring to assess the effectiveness of disinfection and sterilization procedures, and to determine the presence and concentration of harmful bacteria in different environments.

Penicillin G is a type of antibiotic that belongs to the class of medications called penicillins. It is a natural antibiotic derived from the Penicillium fungus and is commonly used to treat a variety of bacterial infections. Penicillin G is active against many gram-positive bacteria, as well as some gram-negative bacteria.

Penicillin G is available in various forms, including an injectable solution and a powder for reconstitution into a solution. It works by interfering with the ability of bacteria to form a cell wall, which ultimately leads to bacterial death. Penicillin G is often used to treat serious infections that cannot be treated with other antibiotics, such as endocarditis (inflammation of the inner lining of the heart), pneumonia, and meningitis (inflammation of the membranes surrounding the brain and spinal cord).

It's important to note that Penicillin G is not commonly used for topical or oral treatment due to its poor absorption in the gastrointestinal tract and instability in acidic environments. Additionally, as with all antibiotics, Penicillin G should be used under the guidance of a healthcare professional to ensure appropriate use and to reduce the risk of antibiotic resistance.

Clindamycin is a antibiotic medication used to treat a variety of bacterial infections. It is a type of antibiotic known as a lincosamide, which works by binding to the bacterial ribosome and inhibiting protein synthesis. This leads to the death of the bacteria and helps to clear the infection.

Clindamycin is effective against a wide range of gram-positive and some anaerobic bacteria, making it a useful antibiotic for treating many different types of infections, including skin and soft tissue infections, bone and joint infections, respiratory infections, and dental infections. It is also sometimes used to treat certain types of bacterial vaginal infections.

Like all antibiotics, clindamycin should be used only under the direction of a healthcare provider, as misuse can lead to antibiotic resistance. Additionally, clindamycin can cause side effects such as diarrhea, nausea, and vomiting, and it may increase the risk of developing a serious intestinal infection called Clostridioides difficile-associated diarrhea (CDAD). It is important to follow your healthcare provider's instructions carefully when taking this medication.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

"Staphylococcus hominis" is a species of grampositive, facultatively anaerobic bacteria that belongs to the genus Staphylococcus. It is commonly found on the skin and mucous membranes of humans, particularly in the nostrils and groin area. While it is generally considered to be a commensal organism, meaning that it can exist harmlessly on the body without causing disease, S. hominis has been associated with some types of infections, such as bloodstream infections (bacteremia) and device-related infections (such as catheter-associated infections). However, these infections are relatively rare compared to those caused by other Staphylococcus species like S. aureus.

It's worth noting that while S. hominis is a normal part of the human microbiome, it can sometimes cause infections if it enters the body through a break in the skin or if it colonizes medical devices such as catheters. In these cases, it may be necessary to treat the infection with antibiotics. However, because S. hominis is resistant to many commonly used antibiotics, identifying the specific species of bacteria causing an infection can help guide appropriate treatment decisions.

Erythromycin is a type of antibiotic known as a macrolide, which is used to treat various types of bacterial infections. It works by inhibiting the bacteria's ability to produce proteins, which are necessary for the bacteria to survive and multiply. Erythromycin is often used to treat respiratory tract infections, skin infections, and sexually transmitted diseases. It may also be used to prevent endocarditis (inflammation of the lining of the heart) in people at risk of this condition.

Erythromycin is generally considered safe for most people, but it can cause side effects such as nausea, vomiting, and diarrhea. It may also interact with other medications, so it's important to tell your doctor about all the drugs you are taking before starting erythromycin.

Like all antibiotics, erythromycin should only be used to treat bacterial infections, as it is not effective against viral infections such as the common cold or flu. Overuse of antibiotics can lead to antibiotic resistance, which makes it harder to treat infections in the future.

Cefazolin is a type of antibiotic known as a cephalosporin, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria are not able to grow and multiply, and are eventually destroyed by the body's immune system.

Cefazolin is commonly used to treat infections of the skin, bones, joints, heart, lungs, and urinary tract. It may also be used to prevent infection during surgery. Like all antibiotics, cefazolin is only effective against certain types of bacteria, so it is important to know the specific type of bacteria causing an infection before using this medication.

Cefazolin is usually given as an injection into a vein or muscle, and may be administered in a hospital setting or at home with proper training. The dosage and duration of treatment will depend on the severity and location of the infection, as well as the patient's overall health status.

As with any medication, cefazolin can cause side effects, including diarrhea, nausea, vomiting, headache, and rash. In rare cases, it may also cause serious side effects such as allergic reactions, kidney damage, or abnormal blood clotting. It is important to report any unusual symptoms to a healthcare provider promptly.

It is essential to complete the full course of treatment with cefazolin, even if symptoms improve, to ensure that the infection is fully treated and to reduce the risk of antibiotic resistance.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Cluster analysis is a statistical method used to group similar objects or data points together based on their characteristics or features. In medical and healthcare research, cluster analysis can be used to identify patterns or relationships within complex datasets, such as patient records or genetic information. This technique can help researchers to classify patients into distinct subgroups based on their symptoms, diagnoses, or other variables, which can inform more personalized treatment plans or public health interventions.

Cluster analysis involves several steps, including:

1. Data preparation: The researcher must first collect and clean the data, ensuring that it is complete and free from errors. This may involve removing outlier values or missing data points.
2. Distance measurement: Next, the researcher must determine how to measure the distance between each pair of data points. Common methods include Euclidean distance (the straight-line distance between two points) or Manhattan distance (the distance between two points along a grid).
3. Clustering algorithm: The researcher then applies a clustering algorithm, which groups similar data points together based on their distances from one another. Common algorithms include hierarchical clustering (which creates a tree-like structure of clusters) or k-means clustering (which assigns each data point to the nearest centroid).
4. Validation: Finally, the researcher must validate the results of the cluster analysis by evaluating the stability and robustness of the clusters. This may involve re-running the analysis with different distance measures or clustering algorithms, or comparing the results to external criteria.

Cluster analysis is a powerful tool for identifying patterns and relationships within complex datasets, but it requires careful consideration of the data preparation, distance measurement, and validation steps to ensure accurate and meaningful results.

Superantigens are a unique group of antigens that can cause widespread activation of the immune system. They are capable of stimulating large numbers of T-cells (a type of white blood cell) leading to massive cytokine release, which can result in a variety of symptoms such as fever, rash, and potentially life-threatening conditions like toxic shock syndrome. Superantigens are often produced by certain bacteria and viruses. They differ from traditional antigens because they do not need to be processed and presented by antigen-presenting cells to activate T-cells; instead, they directly bind to the major histocompatibility complex class II molecules and the T-cell receptor's variable region, leading to polyclonal T-cell activation.

Bacterial chromosomes are typically circular, double-stranded DNA molecules that contain the genetic material of bacteria. Unlike eukaryotic cells, which have their DNA housed within a nucleus, bacterial chromosomes are located in the cytoplasm of the cell, often associated with the bacterial nucleoid.

Bacterial chromosomes can vary in size and structure among different species, but they typically contain all of the genetic information necessary for the survival and reproduction of the organism. They may also contain plasmids, which are smaller circular DNA molecules that can carry additional genes and can be transferred between bacteria through a process called conjugation.

One important feature of bacterial chromosomes is their ability to replicate rapidly, allowing bacteria to divide quickly and reproduce in large numbers. The replication of the bacterial chromosome begins at a specific origin point and proceeds in opposite directions until the entire chromosome has been copied. This process is tightly regulated and coordinated with cell division to ensure that each daughter cell receives a complete copy of the genetic material.

Overall, the study of bacterial chromosomes is an important area of research in microbiology, as understanding their structure and function can provide insights into bacterial genetics, evolution, and pathogenesis.

Autolysis is the process of self-digestion that occurs when living cells are broken down and destroyed through the action of their own enzymes. This term is often used in the context of biological or medical research, particularly in studies involving cell death and tissue breakdown. Autolysis can occur as a result of injury, disease, or programmed cell death (apoptosis). It's important to note that autolysis is different from necrosis, which is the premature death of cells due to external factors such as infection, toxins, or trauma.

Hemolysins are a type of protein toxin produced by certain bacteria, fungi, and plants that have the ability to damage and destroy red blood cells (erythrocytes), leading to their lysis or hemolysis. This results in the release of hemoglobin into the surrounding environment. Hemolysins can be classified into two main categories:

1. Exotoxins: These are secreted by bacteria and directly damage host cells. They can be further divided into two types:
* Membrane attack complex/perforin-like proteins (MACPF): These hemolysins create pores in the membrane of red blood cells, disrupting their integrity and causing lysis. Examples include alpha-hemolysin from Staphylococcus aureus and streptolysin O from Streptococcus pyogenes.
* Enzymatic hemolysins: These hemolysins are enzymes that degrade specific components of the red blood cell membrane, ultimately leading to lysis. An example is streptolysin S from Streptococcus pyogenes, which is a thiol-activated, oxygen-labile hemolysin.
2. Endotoxins: These are part of the outer membrane of Gram-negative bacteria and can cause indirect hemolysis by activating the complement system or by stimulating the release of inflammatory mediators from host cells.

Hemolysins play a significant role in bacterial pathogenesis, contributing to tissue damage, impaired immune responses, and disease progression.

Carrier proteins, also known as transport proteins, are a type of protein that facilitates the movement of molecules across cell membranes. They are responsible for the selective and active transport of ions, sugars, amino acids, and other molecules from one side of the membrane to the other, against their concentration gradient. This process requires energy, usually in the form of ATP (adenosine triphosphate).

Carrier proteins have a specific binding site for the molecule they transport, and undergo conformational changes upon binding, which allows them to move the molecule across the membrane. Once the molecule has been transported, the carrier protein returns to its original conformation, ready to bind and transport another molecule.

Carrier proteins play a crucial role in maintaining the balance of ions and other molecules inside and outside of cells, and are essential for many physiological processes, including nerve impulse transmission, muscle contraction, and nutrient uptake.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Bacterial adhesion is the initial and crucial step in the process of bacterial colonization, where bacteria attach themselves to a surface or tissue. This process involves specific interactions between bacterial adhesins (proteins, fimbriae, or pili) and host receptors (glycoproteins, glycolipids, or extracellular matrix components). The attachment can be either reversible or irreversible, depending on the strength of interaction. Bacterial adhesion is a significant factor in initiating biofilm formation, which can lead to various infectious diseases and medical device-associated infections.

Disk diffusion antimicrobial susceptibility tests, also known as Kirby-Bauer tests, are laboratory methods used to determine the effectiveness of antibiotics against a specific bacterial strain. This test provides a simple and standardized way to estimate the susceptibility or resistance of a microorganism to various antibiotics.

In this method, a standardized inoculum of the bacterial suspension is spread evenly on the surface of an agar plate. Antibiotic-impregnated paper disks are then placed on the agar surface, allowing the diffusion of the antibiotic into the agar. After incubation, the zone of inhibition surrounding each disk is measured. The size of the zone of inhibition correlates with the susceptibility or resistance of the bacterial strain to that specific antibiotic.

The results are interpreted based on predefined criteria established by organizations such as the Clinical and Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST). These interpretive criteria help categorize the susceptibility of the bacterial strain into one of three categories: susceptible, intermediate, or resistant.

It is important to note that disk diffusion tests have limitations and may not always accurately predict clinical outcomes. However, they remain a valuable tool in guiding empirical antibiotic therapy and monitoring antimicrobial resistance trends.

Staphylococcal food poisoning is a type of foodborne illness caused by the consumption of foods contaminated with enterotoxin-producing strains of Staphylococcus aureus bacteria. The ingestion of these toxins can lead to rapid onset of symptoms, typically within 1-6 hours after eating the contaminated food.

The most common symptoms include nausea, vomiting, stomach cramps, and diarrhea. These symptoms usually last for around 24-48 hours but can sometimes persist for a few days. It is important to note that staphylococcal food poisoning does not typically cause fever or bloody stools.

The bacteria that cause this type of food poisoning are often found on the skin and noses of healthy people, as well as in foods such as meats, dairy products, and eggs. Improper handling, storage, or preparation of these foods can lead to contamination with S. aureus, allowing the bacteria to multiply and produce harmful enterotoxins.

To prevent staphylococcal food poisoning, it is essential to maintain good hygiene practices when handling food, keep food at safe temperatures during storage and preparation, and avoid cross-contamination between raw and cooked foods.

Aminoglycosides are a class of antibiotics that are derived from bacteria and are used to treat various types of infections caused by gram-negative and some gram-positive bacteria. These antibiotics work by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death.

Some examples of aminoglycosides include gentamicin, tobramycin, neomycin, and streptomycin. These antibiotics are often used in combination with other antibiotics to treat severe infections, such as sepsis, pneumonia, and urinary tract infections.

Aminoglycosides can have serious side effects, including kidney damage and hearing loss, so they are typically reserved for use in serious infections that cannot be treated with other antibiotics. They are also used topically to treat skin infections and prevent wound infections after surgery.

It's important to note that aminoglycosides should only be used under the supervision of a healthcare professional, as improper use can lead to antibiotic resistance and further health complications.

Gram-positive bacterial infections refer to illnesses or diseases caused by Gram-positive bacteria, which are a group of bacteria that turn purple when stained using the Gram stain method. This staining technique is used in microbiology to differentiate between two main types of bacteria based on their cell wall composition.

Gram-positive bacteria have a thick layer of peptidoglycan in their cell walls, which retains the crystal violet stain used in the Gram staining process. Some common examples of Gram-positive bacteria include Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis.

Gram-positive bacterial infections can range from mild skin infections to severe and life-threatening conditions such as pneumonia, meningitis, and sepsis. The symptoms of these infections depend on the type of bacteria involved and the location of the infection in the body. Treatment typically involves the use of antibiotics that are effective against Gram-positive bacteria, such as penicillin, vancomycin, or clindamycin. However, the emergence of antibiotic resistance among Gram-positive bacteria is a growing concern and can complicate treatment in some cases.

Nasal mucosa refers to the mucous membrane that lines the nasal cavity. It is a delicate, moist, and specialized tissue that contains various types of cells including epithelial cells, goblet cells, and glands. The primary function of the nasal mucosa is to warm, humidify, and filter incoming air before it reaches the lungs.

The nasal mucosa produces mucus, which traps dust, allergens, and microorganisms, preventing them from entering the respiratory system. The cilia, tiny hair-like structures on the surface of the epithelial cells, help move the mucus towards the back of the throat, where it can be swallowed or expelled.

The nasal mucosa also contains a rich supply of blood vessels and immune cells that help protect against infections and inflammation. It plays an essential role in the body's defense system by producing antibodies, secreting antimicrobial substances, and initiating local immune responses.

Virulence, in the context of medicine and microbiology, refers to the degree or severity of damage or harm that a pathogen (like a bacterium, virus, fungus, or parasite) can cause to its host. It is often associated with the ability of the pathogen to invade and damage host tissues, evade or suppress the host's immune response, replicate within the host, and spread between hosts.

Virulence factors are the specific components or mechanisms that contribute to a pathogen's virulence, such as toxins, enzymes, adhesins, and capsules. These factors enable the pathogen to establish an infection, cause tissue damage, and facilitate its transmission between hosts. The overall virulence of a pathogen can be influenced by various factors, including host susceptibility, environmental conditions, and the specific strain or species of the pathogen.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Agar is a substance derived from red algae, specifically from the genera Gelidium and Gracilaria. It is commonly used in microbiology as a solidifying agent for culture media. Agar forms a gel at relatively low temperatures (around 40-45°C) and remains stable at higher temperatures (up to 100°C), making it ideal for preparing various types of culture media.

In addition to its use in microbiology, agar is also used in other scientific research, food industry, and even in some artistic applications due to its unique gelling properties. It is important to note that although agar is often used in the preparation of food, it is not typically consumed as a standalone ingredient by humans or animals.

N-Acetylmuramoyl-L-alanine Amidase (also known as NAM Amidase or MurNAc-LAA Amidase) is an enzyme that plays a crucial role in the bacterial cell wall metabolism. It is responsible for cleaving the amide bond between N-acetylmuramic acid (NAM) and L-alanine (L-Ala) in the peptidoglycan, which is a major component of the bacterial cell wall.

The enzyme's systematic name is N-acetylmuramoyl-L-alanine amidase, but it can also be referred to as:

* N-acetylmuramic acid lyase
* Peptidoglycan N-acetylmuramoylhydrolase
* N-acetylmuramoyl-L-alanine glycohydrolase
* N-acetylmuramoyl-L-alanine amidohydrolase

N-Acetylmuramoyl-L-alanine Amidase is an essential enzyme for bacterial cell division and morphogenesis, as it facilitates the separation of daughter cells by cleaving peptidoglycan crosslinks. This enzyme has been studied extensively due to its potential as a target for developing new antibiotics that can selectively inhibit bacterial cell wall biosynthesis without affecting human cells.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

Glycopeptides are a class of antibiotics that are characterized by their complex chemical structure, which includes both peptide and carbohydrate components. These antibiotics are produced naturally by certain types of bacteria and are effective against a range of Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE).

The glycopeptide antibiotics work by binding to the bacterial cell wall precursor, preventing the cross-linking of peptidoglycan chains that is necessary for the formation of a strong and rigid cell wall. This leads to the death of the bacteria.

Examples of glycopeptides include vancomycin, teicoplanin, and dalbavancin. While these antibiotics have been used successfully for many years, their use is often limited due to concerns about the emergence of resistance and potential toxicity.

"Pseudomonas aeruginosa" is a medically important, gram-negative, rod-shaped bacterium that is widely found in the environment, such as in soil, water, and on plants. It's an opportunistic pathogen, meaning it usually doesn't cause infection in healthy individuals but can cause severe and sometimes life-threatening infections in people with weakened immune systems, burns, or chronic lung diseases like cystic fibrosis.

P. aeruginosa is known for its remarkable ability to resist many antibiotics and disinfectants due to its intrinsic resistance mechanisms and the acquisition of additional resistance determinants. It can cause various types of infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, dermatitis, and severe bloodstream infections known as sepsis.

The bacterium produces a variety of virulence factors that contribute to its pathogenicity, such as exotoxins, proteases, and pigments like pyocyanin and pyoverdine, which aid in iron acquisition and help the organism evade host immune responses. Effective infection control measures, appropriate use of antibiotics, and close monitoring of high-risk patients are crucial for managing P. aeruginosa infections.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Cefamandole is a second-generation cephalosporin antibiotic, which is a type of antibacterial medication used to treat various infections caused by bacteria. It works by interfering with the ability of bacteria to form cell walls, resulting in weakening and eventual death of the bacterial cells.

Cefamandole has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, making it useful for treating a variety of infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and septicemia.

Like other cephalosporins, cefamandole is generally well-tolerated and has a low incidence of serious side effects. However, it can cause gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as allergic reactions in some people. It may also interact with other medications, so it's important to inform your healthcare provider of all the medications you are taking before starting cefamandole therapy.

It is important to note that antibiotics should only be used to treat bacterial infections and not viral infections, as they are not effective against viruses and can contribute to the development of antibiotic resistance.

Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They contain a beta-lactam ring in their chemical structure, which is responsible for their antibacterial activity. The beta-lactam ring inhibits the bacterial enzymes necessary for cell wall synthesis, leading to bacterial death. Beta-lactams are commonly used to treat a wide range of bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone and joint infections. However, some bacteria have developed resistance to beta-lactams through the production of beta-lactamases, enzymes that can break down the beta-lactam ring and render the antibiotic ineffective. To overcome this resistance, beta-lactam antibiotics are often combined with beta-lactamase inhibitors, which protect the beta-lactam ring from degradation.

"Gram-Positive Cocci" is a term used in microbiology, which refers to a specific type of bacteria that appear round (cocci) in shape and stain purple when subjected to the Gram staining method. The Gram staining technique is a fundamental laboratory method used to differentiate bacterial species based on their cell wall composition.

Gram-positive bacteria have a thick peptidoglycan layer in their cell walls, which retains the crystal violet stain used in the Gram staining process, resulting in a purple color. Some common examples of Gram-Positive Cocci include Staphylococcus aureus and Streptococcus pyogenes. These bacteria can cause various infections, ranging from skin and soft tissue infections to severe systemic illnesses. It is essential to identify the type and nature of bacterial pathogens accurately for appropriate antimicrobial therapy and effective patient management.

Blood is the fluid that circulates in the body of living organisms, carrying oxygen and nutrients to the cells and removing carbon dioxide and other waste products. It is composed of red and white blood cells suspended in a liquid called plasma. The main function of blood is to transport oxygen from the lungs to the body's tissues and carbon dioxide from the tissues to the lungs. It also transports nutrients, hormones, and other substances to the cells and removes waste products from them. Additionally, blood plays a crucial role in the body's immune system by helping to fight infection and disease.

Mastitis is a medical condition characterized by inflammation of the breast tissue, usually caused by an infection. It typically occurs in breastfeeding women, when bacteria from the baby's mouth enter the milk ducts through a cracked or damaged nipple, leading to infection and inflammation. However, mastitis can also occur in non-breastfeeding women, often as a result of blocked milk ducts or milk remaining in the breast after weaning.

Symptoms of mastitis may include breast pain, tenderness, swelling, warmth, redness, and fever. In some cases, pus or blood may be present in the breast milk. If left untreated, mastitis can lead to more severe complications such as abscess formation. Treatment typically involves antibiotics to clear the infection, pain relief medication, and continued breastfeeding or pumping to prevent further blockage of the milk ducts.

Bacterial adhesins are proteins or structures on the surface of bacterial cells that allow them to attach to other cells or surfaces. This ability to adhere to host tissues is an important first step in the process of bacterial infection and colonization. Adhesins can recognize and bind to specific receptors on host cells, such as proteins or sugars, enabling the bacteria to establish a close relationship with the host and evade immune responses.

There are several types of bacterial adhesins, including fimbriae, pili, and non-fimbrial adhesins. Fimbriae and pili are thin, hair-like structures that extend from the bacterial surface and can bind to a variety of host cell receptors. Non-fimbrial adhesins are proteins that are directly embedded in the bacterial cell wall and can also mediate attachment to host cells.

Bacterial adhesins play a crucial role in the pathogenesis of many bacterial infections, including urinary tract infections, respiratory tract infections, and gastrointestinal infections. Understanding the mechanisms of bacterial adhesion is important for developing new strategies to prevent and treat bacterial infections.

'Infection Control' is a set of practices, procedures, and protocols designed to prevent the spread of infectious agents in healthcare settings. It includes measures to minimize the risk of transmission of pathogens from both recognized and unrecognized sources, such as patients, healthcare workers, visitors, and the environment.

Infection control strategies may include:

* Hand hygiene (handwashing and use of alcohol-based hand sanitizers)
* Use of personal protective equipment (PPE), such as gloves, masks, gowns, and eye protection
* Respiratory etiquette, including covering the mouth and nose when coughing or sneezing
* Environmental cleaning and disinfection
* Isolation precautions for patients with known or suspected infectious diseases
* Immunization of healthcare workers
* Safe injection practices
* Surveillance and reporting of infections and outbreaks

The goal of infection control is to protect patients, healthcare workers, and visitors from acquiring and transmitting infections.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Prosthesis-related infections, also known as prosthetic joint infections (PJIs), are infections that occur around or within a prosthetic device, such as an artificial joint. These infections can be caused by bacteria, fungi, or other microorganisms and can lead to serious complications if not treated promptly and effectively.

Prosthesis-related infections can occur soon after the implantation of the prosthetic device (early infection) or months or even years later (late infection). Early infections are often caused by bacteria that enter the surgical site during the procedure, while late infections may be caused by hematogenous seeding (i.e., when bacteria from another source spread through the bloodstream and settle in the prosthetic device) or by contamination during a subsequent medical procedure.

Symptoms of prosthesis-related infections can include pain, swelling, redness, warmth, and drainage around the affected area. In some cases, patients may also experience fever, chills, or fatigue. Diagnosis typically involves a combination of clinical evaluation, laboratory tests (such as blood cultures, joint fluid analysis, and tissue biopsy), and imaging studies (such as X-rays, CT scans, or MRI).

Treatment of prosthesis-related infections usually involves a combination of antibiotics and surgical intervention. The specific treatment approach will depend on the type and severity of the infection, as well as the patient's overall health status. In some cases, it may be necessary to remove or replace the affected prosthetic device.

Streptococcus is a genus of Gram-positive, spherical bacteria that typically form pairs or chains when clustered together. These bacteria are facultative anaerobes, meaning they can grow in the presence or absence of oxygen. They are non-motile and do not produce spores.

Streptococcus species are commonly found on the skin and mucous membranes of humans and animals. Some strains are part of the normal flora of the body, while others can cause a variety of infections, ranging from mild skin infections to severe and life-threatening diseases such as sepsis, meningitis, and toxic shock syndrome.

The pathogenicity of Streptococcus species depends on various virulence factors, including the production of enzymes and toxins that damage tissues and evade the host's immune response. One of the most well-known Streptococcus species is Streptococcus pyogenes, also known as group A streptococcus (GAS), which is responsible for a wide range of clinical manifestations, including pharyngitis (strep throat), impetigo, cellulitis, necrotizing fasciitis, and rheumatic fever.

It's important to note that the classification of Streptococcus species has evolved over time, with many former members now classified as different genera within the family Streptococcaceae. The current classification system is based on a combination of phenotypic characteristics (such as hemolysis patterns and sugar fermentation) and genotypic methods (such as 16S rRNA sequencing and multilocus sequence typing).

DNA Sequence Analysis is the systematic determination of the order of nucleotides in a DNA molecule. It is a critical component of modern molecular biology, genetics, and genetic engineering. The process involves determining the exact order of the four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - in a DNA molecule or fragment. This information is used in various applications such as identifying gene mutations, studying evolutionary relationships, developing molecular markers for breeding, and diagnosing genetic diseases.

The process of DNA Sequence Analysis typically involves several steps, including DNA extraction, PCR amplification (if necessary), purification, sequencing reaction, and electrophoresis. The resulting data is then analyzed using specialized software to determine the exact sequence of nucleotides.

In recent years, high-throughput DNA sequencing technologies have revolutionized the field of genomics, enabling the rapid and cost-effective sequencing of entire genomes. This has led to an explosion of genomic data and new insights into the genetic basis of many diseases and traits.

"Methicillin-resistant Staphylococcus aureus as community pathogen". Symposium on Community-Associated Methicillin-resistant ... aureus to be resistant to oxacillin. Like all S. aureus (also abbreviated SA at times), methicillin-resistant S. aureus is a ... "Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive staphylococcus aureus ... Methicillin-resistant Staphylococcus aureus (MRSA) is a group of gram-positive bacteria that are genetically distinct from ...
... and bacteria that are commonly involved include staphylococcus, including methicillin resistant staphylococcus aureus (MRSA), ... Methicillin-resistant Staphylococcus aureus). Initial diagnosis of diabetic foot infections is made primarily via thorough ... Treatment of mild-moderate infections should last 1-2 weeks and typically requires oral antibiotics that cover staphylococci ... Infections are commonly polymicrobial and involve antibiotic-resistant strains of organisms e.g. MRSA ( ...
Methicillin-resistant Staphylococcus aureus (MRSA) has been identified in pigs and humans raising concerns about the role of ... "Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers" (PDF). Archived from the original (PDF) on ... "High prevalance methicillin resistant Staphylococcus aureus in pigs" (PDF). Retrieved November 14, 2010.[dead link] Rubin, JE; ... "Joint scientific report of ECDC, EFSA and EMEA on methicillin resistant Staphylococcus aureus (MRSA) in livestock, companion ...
"Methicillin-resistant Staphylococcus aureus (MRSA) Infections". cdc.gov. September 10, 2013. Retrieved 15 February 2015. Vetter ... may think that a wound is a spider bite when it is actually an infection with methicillin-resistant Staphylococcus aureus (MRSA ...
Such organisms include methicillin-resistant Staphylococcus aureus, which has developed resistance to flucloxacillin and other ... It is not effective against methicillin-resistant Staphylococcus aureus (MRSA). It is taken by mouth or given by injection into ... ISBN 978-0-85711-369-6. "Methicillin-resistant Staphylococcus aureus (MRSA)" (PDF). NHS. 2005. p. 3. Retrieved 11 December 2020 ... However, like methicillin, it is less potent than benzylpenicillin against non-β-lactamase-producing Gram-positive bacteria.[ ...
doi:10.1016/s1068-607x(97)00012-7. Waness, Abdelkarim (2010-01-01). "Revisiting methicillin-resistant Staphylococcus aureus ... STAPLETON, PAUL D.; TAYLOR, PETER W. (2002-01-01). "Methicillin resistance in Staphylococcus aureus". Science Progress. 85 (Pt ... These methoxy groups allow methicillin to be used against penicillinase producing bacteria that would otherwise be resistant to ... Methicillin is another derivative of penicillin and was discovered in the late 1950s, the key difference between penicillin and ...
"Methicillin-Resistant Staphylococcus Aureus (MRSA) and Athletics". NCAA.org - The Official Site of the NCAA. Retrieved April 1 ... "Methicillin-resistant Staphylococcus Aureus (MRSA) Infections , CDC". www.cdc.gov. Retrieved April 1, 2016. "Ringworm: ... MRSA stands for Methicillin-Resistant Staphylococcus, which is a form of a staph. Any athlete who develops a skin infection ... Impetigo comes from a bacterium known as staphylococcus aureus. Certain sports. Participating in sports like wrestling and ...
Active against methicillin-resistant Staphylococcus aureus". AMB Express. 4: 50. doi:10.1186/s13568-014-0050-y. PMC 4077001. ...
Epidemiology of Methicillin-resistant Staphylococcus aureus Harbarth, S; Rutschmann, O; Sudre, P; Pittet, D (1998). "Impact of ... Control of methicillin-resistant Staphylococcus aureus Harbarth, S; Dharan, S; Liassine, N; Herrault, P; Auckenthaler, R; ... 2008). "Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in ... 2008). "Universal Screening for Methicillin-Resistant Staphylococcus aureus at Hospital Admission and Nosocomial Infection in ...
... aureus isolates were penicillin-resistant; by 1960, this had risen to 80%. Methicillin-resistant Staphylococcus aureus (MRSA, ... Now, methicillin-resistant Staphylococcus aureus (MRSA) is not only a human pathogen causing a variety of infections, such as ... Methicillin-resistant staphylococcus aureus carriage among health-care professionals of a tertiary care hospital. Asian J Pharm ... Sing A, Tuschak C, Hörmansdorfer S (March 2008). "Methicillin-resistant Staphylococcus aureus in a family and its pet cat". The ...
Nutmeg) Seeds against Methicillin-Resistant Staphylococcus aureus". Molecules (Basel, Switzerland). 26 (15): 4662. doi:10.3390/ ...
O-BC30T, against Methicillin-Resistant Staphylococcus aureus". Antimicrobial Agents and Chemotherapy. Washington, DC: American ...
O-BC30T, against Methicillin-Resistant Staphylococcus aureus". Antimicrobial Agents and Chemotherapy. 47 (2): 480-488. doi: ... Isnansetyo, A.; Kamei, Y. (2009). "Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial ... nov., a novel marine bacterium that produces phenolic anti-methicillin-resistant Staphylococcus aureus substances". ... Those two substances show antibacterial activity against methicillin-resistant Staphylococcus aureus. Isnansetyo, A.; Kamei, Y ...
Ureaplasma urealyticum Methicillin-resistant Staphylococcus aureus Group B streptococcus Irritation of the genital area: for ... Sharma P, Singal A (September 1999). "Methicillin-resistant Staphylococcus aureus non-gonococcal urethritis". Acta Dermato- ... if macrolide-resistant M. genitalium infection is demonstrated Appropriate treatment for these individuals may require further ...
August 2014). "Anthracimycin activity against contemporary methicillin-resistant Staphylococcus aureus". The Journal of ... and against methicillin-resistant Staphylococcus aureus (MRSA). Anthracimycin was first isolated from a species of marine ... This included strains of methicillin-susceptible, methicillin-resistant (MRSA), and vancomycin-resistant strains. Unfortunately ... anthracimycin was screened against a panel of Staphylococcus aureus strains both in vivo and in vitro. All strains of S. aureus ...
MRSA is methicillin-resistant Staphylococcus aureus, a bacterium. MRSA may also refer to: MrsA (gene), for the enzyme 2- ... British producer and DJ Methicillin-resistant Staphylococcus epidermidis (MRSE) Sá, a surname This disambiguation page lists ...
Nagaraju U, Bhat G, Kuruvila M, Pai GS, Babu RP (2004). "Methicillin-resistant Staphylococcus aureus in community-acquired ... It is most commonly caused by infection by the bacterium Staphylococcus aureus, resulting in a painful swollen area on the skin ... Fever and chills are signs of sepsis and indicate immediate treatment . Staphylococcus aureus has the ability to acquire ... "Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia". Clin ...
... methicillin and oxacillin in methicillin-susceptible and methicillin-resistant Staphylococcus aureus detected by dilution and ... Such organisms include methicillin-resistant Staphylococcus aureus (MRSA).[better source needed] Like other β-lactam ... It is active against beta-lactamase-producing organisms such as Staphylococcus aureus, which would otherwise be resistant to ... vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains". Annals of Clinical Microbiology and ...
... and methicillin-susceptible, methicillin-resistant, and tetracycline-resistant Staphylococcus aureus. In year 2006, LaPlante ... LaPlante conducted study in 2012 focused the Methicillinresistant Staphylococcus aureus (MRSA), its treatment and risk factors ... She also quantified the biofilm formation of methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates and ... "Community-Associated Methicillin-Resistant Staphylococcus aureus : A Review". Pharmacotherapy. 25 (1): 74-85. doi:10.1592/phco. ...
Kollef MH (December 2009). "New antimicrobial agents for methicillin-resistant Staphylococcus aureus". Crit Care Resusc. 11 (4 ... a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus". Clin. Infect ... A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)". Clinical Medicine Reviews in ... First-generation cephalosporins are active predominantly against Gram-positive bacteria, such as Staphylococcus and ...
Major bacteria resistant to cefoxitin include: methicillin-resistant Staphylococcus aureus Enterococci Listeria monocytogenes ... MRSA, or methicillin-resistant Staphylococcus aureus is a strain that has acquired resistance to cefoxitin via this gene. For ... Paterson GK, Harrison EM, Holmes MA (January 2014). "The emergence of mecC methicillin-resistant Staphylococcus aureus". Trends ... Staphylococci that are resistant to methicillin and oxacillin should also be considered clinically resistant to cefoxitin even ...
... of Staphylococcus aureus. It is present in the majority of community-associated methicillin-resistant Staphylococcus aureus (CA ... Deresinski S (February 2005). "Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic ... "Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin". Lab Invest. 87 (1): 3 ... "Community-Associated Methicillin Resistant Staphylococcus aureus (CA-MRSA)". Retrieved 2007-11-01. Szmiegielski S; Prevost G; ...
"The emergence and evolution of methicillin-resistant Staphylococcus aureus". Trends in Microbiology. 9 (10): 486-93. doi: ... and it might be concluded that its genome is resistant to HGT. However, subsequent analysis using phylogenetic methods ...
For people with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in the setting of vancomycin failure the ... Vancomycin-resistant Staphylococcus aureus (VRSA) are strains of Staphylococcus aureus that have acquired resistance to the ... p. 8. Appelbaum PC (November 2007). "Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA ... "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility". Journal of Antimicrobial ...
Tenover FC, Goering RV (2009). "Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology". J ... These PVL-producing strains are frequently methicillin resistant (MRSA). In developing countries with high rates of HIV ... Adults are more commonly affected by community-acquired Staphylococcus aureus, S. pneumoniae and K. pneumoniae. Gram-negative ... The most common pathogens responsible for NP are Streptococcus pneumonia, Staphylococcus aureus and Klebsiella pneumoniae. ...
"Methicillin-resistant Staphylococcus aureus in two child care centers". The Journal of Infectious Diseases. 178 (2): 577-580. ... and methicillin-resistant Staphylococcus aureus (MRSA). Murphy's studies advanced understanding of how these organisms spread ...
"Molecular epidemiology of enteritis-causing methicillin-resistant Staphylococcus aureus". Journal of Hospital Infection. 62 (1 ... S. aureus can cause a range of illnesses from minor skin infections to Staphylococcus aureus food poisoning enteritis. Since ... Staphylococcus aureus is a true food poisoning organism. It produces a heat stable enterotoxin when allowed to grow for several ... Common symptoms of Staphylococcus aureus food poisoning include: a rapid onset which is usually 1-6 hours, nausea, explosive ...
... is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA), most Enterococcus, ... Cefalexin does not treat methicillin-resistant Staphylococcus aureus infections. Cefalexin is a useful alternative to ...
"The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)". Proc Natl Acad Sci USA. 99 (11): 7687-7692. ... Extremophiles have been known to survive for a prolonged time in a vacuum, and can be highly resistant to radiation, which may ... This rapid evolution is important in medicine, as it has led to the development of multidrug resistant pathogenic bacteria, ... superbugs, that are resistant to antibiotics. A possible transitional form of microorganism between a prokaryote and a ...
Methicillin-resistant Staphylococcus aureus (MRSA) Quinupristin/dalfopristin Hamilton-Miller JM (June 1991). "From foreign ... It is active against methicillin-resistant Staphylococcus aureus (MRSA). Its usefulness for severe infections, however, may be ... Despite the macrolide component, it is effective against erythromycin-resistant staphylococci and streptococci. ... In vitro activity of the pristinamycin against the isolated staphylococci in the french hospitals in 1999-2000]". Pathologie- ...
"Methicillin-resistant Staphylococcus aureus as community pathogen". Symposium on Community-Associated Methicillin-resistant ... aureus to be resistant to oxacillin. Like all S. aureus (also abbreviated SA at times), methicillin-resistant S. aureus is a ... "Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive staphylococcus aureus ... Methicillin-resistant Staphylococcus aureus (MRSA) is a group of gram-positive bacteria that are genetically distinct from ...
Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by S aureus bacteria and can be fatal. There are 2 major ...
Strains that are oxacillin and methicillin resistant, historically termed methicillin-resistant S. aureus (MRSA), are resistant ... Laboratory Detection of: Oxacillin/Methicillin-resistant Staphylococcus aureus. ... When resistance was first described in 1961, methicillin was used to test and treat infections caused by S. aureus. However, ... However, many S. aureus strains, while resistant to penicillin, remain susceptible to penicillinase-stable penicillins, such as ...
Methicillin - Resistant Staphylococcus aureus (MRSA) (L35_C) Data File: L35_C.xpt First Published: November 2006. Last Revised ... where the rapid emergence of methicillin-resistant S. aureus (MRSA) and the appearance of S. aureus isolates with resistance to ... LBXMS2 - S. aureus present 2. Variable Name: LBXMS2. SAS Label: S. aureus present 2. English Text: S. aureus present 2 Target: ... LBXMS1 - S. aureus present 1. Variable Name: LBXMS1. SAS Label: S. aureus present 1. English Text: S. aureus present 1. Target ...
Its not a spider bite, its community-acquired methicillin-resistant Staphylococcus aureus J Am Board Fam Pract. 2004 May-Jun; ... its community-acquired methicillin-resistant Staphylococcus aureus ...
... methicillin-sensitive S. aureus (MSSA), methicillin-resistant and methicillin-sensitive coagulase-negative staphylococci (MRCNS ... "1. A method for detecting the presence of MREJ type i, ii, iii and vii methicillin-resistant Staphylococcus aureus (MRSA) ... "1. A method for detecting the presence of MREJ type i, ii, iii and vii methicillin-resistant Staphylococcus aureus (MRSA) ... T 1146/15 (Detection methicillin-resistant Staphylococcus aureus/GENEOHM SCIENCES CANADA) 22-11-2021. ...
Methicillin-resistant S. aureus (MRSA) emerged 50 years ago as a nosocomial pathogen but in the last decade it has also become ... Methicillin-resistant S. aureus (MRSA) emerged fifty years ago as a nosocomial pathogen but in the last decade it has also ... Some animal S. aureus lineages have derived from human strains following profound genetic adaptation determining a change in ... Some animal S. aureus lineages have derived from human strains following profound genetic adaptation determining a change in ...
Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as a bacterial pathogen in patients with cystic fibrosis (CF) ... Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as a bacterial pathogen in patients with cystic fibrosis (CF) ... Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using ...
... and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) obtained from ready-to-eat (RTE) foods in ... Characterization of methicillin-resistant Staphylococcus aureus from ready-to-eat foods in China. ... Characterization of methicillin-resistant Staphylococcus aureus from ready-to-eat foods in China. by Compuscript Ltd ... Citation: Characterization of methicillin-resistant Staphylococcus aureus from ready-to-eat foods in China (2023, September 4) ...
Policy for methicillin-resistant Staphylococcus aureus. Leiden: Dutch Workingparty Infection Prevention, 2005. www.wip.nl/UK/ ... Patients with increased risk of colonisation with Methicillin-resistant Staphylococcus aureus (MRSA) are screened before ... Harbarth S. Control of endemic methicillin-resistant Staphylococcus aureus-recent advances and future challenges. Clin ... Should children adopted from abroad be screened for methicillin-resistant Staphylococcus aureus?. ...
... testing the antibiotic resistance-modifying activity of Turnera ulmifolia against methicillin-resistant Staphylococcus aureus ... Some Staphylococcus species are frequently recognized as etiological agents of many animal and human opportunistic infections ... Staphylococcus genus is widely spread in nature being part of the indigenous microbiota of skin and mucosa of animal and birds ... potentiation of the antibiotic activity against methicillin - resistant Staphylococcus aureus by Turnera ulmifolia L. BMC ...
MRSA Is Methicillin Resistant Staph Aureus *It is a bacteria that is ... – A free PowerPoint PPT presentation (displayed ... Methicillin-resistant staphylococcus aureus (MRSA) is a type of staphylococcus aureus which is resistant to methicillin, a beta ... Methicillin Resistant Staphylococcus aureus (MRSA) - Methicillin Resistant Staphylococcus aureus (MRSA) What is it ? A flesh- ... Methicillin Resistant Staphylococcus Aureus. 1. Methicillin Resistant Staphylococcus Aureus*Barbara Jennings-Spring ...
Discusses methicillin-resistant Staphylococcus aureus (MRSA), a type of staph bacteria. Covers how it is spread. Discusses ... What is methicillin-resistant Staphylococcus aureus (MRSA)?. Methicillin-resistant Staphylococcus aureus (MRSA) is a type of ... Most cases of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) begin as mild skin infections such as ... This type of MRSA is called community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). ...
Methicillin-resistant Staphylococcus aureus (MRSA) remains an important nosocomial pathogen, although the organism has ... Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A ... The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001 ... Surveillance for Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals - A Report Update from the Canadian ...
Methicillin-Resistant Staphylococcus aureus in Marine Mammals Cite CITE. Title : Methicillin-Resistant Staphylococcus aureus in ... 2009). Methicillin-Resistant Staphylococcus aureus in Marine Mammals. 15(12). Faires, Meredith C. et al. "Methicillin-Resistant ... Methicillin-resistant Staphylococcus aureus (MRSA) infection in humans and animals is concerning. In 2012, our evaluation of a ... "Methicillin-Resistant Staphylococcus aureus in Marine Mammals" vol. 15, no. 12, 2009. Export RIS Citation Information.. ...
Determination of methicillin-resistant Staphylococcus aureus was carried out with the aid of Oxacillin sensitivity disc to test ... This study is aimed at investigating biofilm and enterotoxin producing capacity of methicillin-resistant Staphylococcus aureus ... Evaluation of biofilm and enterotoxin producing capacity of methicillin-resistant ,i,Staphylococcus aureus,/i, isolated from ... The Methicillin-resistant Staphylococcus aureus (MRSA) isolates were screened to determine their biofilm producing ability ...
Prevalence of Methicillin Resistant Staphylococcus aureus Carriage Amongst Healthcare Workers of Critical Care Units in ... Staphylococcus aureus, Healthcare Workers, MRSA carriage, MDR MRSA. Abstract. Staphylococcus aureus is responsible for numerous ... Prevalence of Methicillin Resistant Staphylococcus aureus Carriage Amongst Healthcare Workers of Critical Care Units in ... Methicillin resistance was detected using both disc diffusion assay and gene specific polymerase chain reaction. S. aureus ...
... the role of methicillin resistant Staphylococcus aureus (MRSA) in the pathogenesis of this disease remains enigmatic despite a ... exp OR methicillin AND resistant AND (staphylococcus/exp OR staphylococcus) AND aureus OR mrsa/exp OR mrsa AND (colitis/ ... Lee HL, Han DS, Kim JP, Kim JB, Park JY, Sohn JH, Hahm JS: A case of methicillin resistant Staphylococcus aureus enterocolitis ... Yoshida Y: Methicillin-resistant Staphylococcus aureus proliferation in the rat gut is influenced by gastric acid inhibition ...
... for methicillin-resistant Staphylococcus aureus (MRSA). Methods In total, 229 MRSA isolates from blood cultures collected ... Therefore, to reduce inappropriate antibiotic use and mitigate the emergence of resistant strains, we recommend using ... the first line antibiotic for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, is often administered ... Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vMaancomycin.. ...
... aureus can be either methicillin-resistant (MRSA) or methicillin-susceptible (MSSA). But MRSA strains are not just resistant to ... Staphylococcus aureus, often called Staph aureus or S. aureus, is a bacterium that is normally carried in the nose of about 30 ... Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Available at: http://www.cdc.gov/ncidod/dhqp/ar_ ... Healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA). Available at: http://www.cdc.gov/ncidod/dhqp/ar_ ...
Change in Methicillin-Resistant Staphylococcus aureus Testing in the Intensive Care Unit as an Antimicrobial Stewardship ...
ASSOCIATION BETWEEN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION AND VITAMIN D DEFICIENCY Open Access. Thomason, Jenna ... ASSOCIATION BETWEEN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION AND VITAMIN D DEFICIENCY () 2018-08-28 16:13:24 -0400 ... D deficiency was significantly associated with Methicillin-resistant Staphylococcus aureus (MRSA) infection. Methods. All ...
Staphylococcus aureus (HA-MRSA) lineage ST 239. Results based on previously uncharacterized isolates from a hospital in ... We describe and validate a novel PCR assay to detect the pandemic hospital-acquired methicillin-resistant ... Rapid Detection of the Pandemic Methicillin-Resistant Staphylococcus aureus Clone ST 239, a Dominant Strain in Asian Hospitals ... Rapid Detection of the Pandemic Methicillin-Resistant Staphylococcus aureus Clone ST 239, a Dominant Strain in Asian Hospitals ...
... aureus. Only one isolate was MRSA (0.18%) which encoded mecA and femA genes as well as SCCmec type IV, whereas Panton-Valentine ... we determined the rate of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) in children admitted to 9 ...
... For this assignment, Part One of your course project, assume the role of Dr. ... CHOOSE - MRSA- Methicillin-resistant Staphylococcus aureusName of Agent: Explain why you chose the name. If it is a biological ...
Watéba, I., Salou, M., Ekouevi, D. et al. P193: Nasal carriage of methicillin resistant Staphylococcus aureus in staff of the ... Methicillin resistant Staphylococcus aureus (MRSA) is a major public health problem found in nosocomial infections. However, ... P193: Nasal carriage of methicillin resistant Staphylococcus aureus in staff of the surgical services of CHU Sylvanus Olympio ... P193: Nasal carriage of methicillin resistant Staphylococcus aureus in staff of the surgical services of CHU Sylvanus Olympio ...
Methicillin-Resistant Staphylococcus aureus*Methicillin-Resistant Staphylococcus aureus. *Methicillin Resistant Staphylococcus ... Staphylococcus aureus [B03.300.390.400.800.750.100]. *Methicillin-Resistant Staphylococcus aureus [B03.300.390.400.800.750. ... "Methicillin-Resistant Staphylococcus aureus" by people in this website by year, and whether "Methicillin-Resistant ... "Methicillin-Resistant Staphylococcus aureus" is a descriptor in the National Library of Medicines controlled vocabulary ...
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a cause of staph infection that is difficult to treat because of resistance to some antibiotics. (cdc.gov)
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a group of gram-positive bacteria that are genetically distinct from other strains of Staphylococcus aureus. (wikipedia.org)
  • MRSA is any strain of S. aureus that has developed (through natural selection) or acquired (through horizontal gene transfer) a multiple drug resistance to beta-lactam antibiotics. (wikipedia.org)
  • After 72 hours, MRSA can take hold in human tissues and eventually become resistant to treatment. (wikipedia.org)
  • an infection by MRSA is called healthcare-associated or hospital-acquired methicillin-resistant S. aureus (HA-MRSA). (wikipedia.org)
  • [ 1 ] Methicillin-resistant Staphylococcus aureus (MRSA) isolates are strains constitutively resistant to β-lactam antimicrobial drugs. (medscape.com)
  • Only a few small analytical or population-based of methicillin-resistant Staphylococcus aureus (MRSA) of- studies have been published ( 12 - 14 ). (cdc.gov)
  • Global transmission of methicillin-resistant Staphylo- Data on MRSA Cases in the Statutory Swedish coccus aureus (MRSA) has been the subject of many Communicable Disease Notifi cation System studies. (cdc.gov)
  • Methicillin-resistant Staphylococcus aureus (MRSA) infection has emerged in patients who do not have the established risk factors. (nih.gov)
  • The infecting strain of MRSA was often (73 percent) resistant to prescribed antimicrobial agents. (nih.gov)
  • Antimicrobial resistance in S. aureus has increased dramatically, particularly in the hospital, where the rapid emergence of methicillin-resistant S. aureus (MRSA) and the appearance of S. aureus isolates with resistance to vancomycin have led to concern that this organism may become untreatable with currently available antimicrobials. (cdc.gov)
  • Isolates resistant to OX (MRSA), intermediate to OX, and every 10th isolate susceptible to OX (MSSA) by disk diffusion are saved for additional testing of organism characteristics. (cdc.gov)
  • The advent of methicillin-resistant Staphylococcus aureus (MRSA) and the frequent and excessive abuse of ventilators have made MRSA pneumonia an inordinate threat to human health. (hindawi.com)
  • These findings indicate that, as a therapeutic agent for MRSA pneumonia, lysostaphin exerts profound protective effects in mice against the morbidity and mortality associated with S. aureus pneumonia. (hindawi.com)
  • At present, methicillin-resistant S. aureus (MRSA) is one of the most commonly identified antibiotic-resistant pathogens in many parts of the world. (hindawi.com)
  • Moreover, accumulating data indicate that MRSA infections are associated with a worse prognosis than methicillin-susceptible S. aureus infections [ 8 - 11 ]. (hindawi.com)
  • MRSA-117 was shown to be resistant to several antibiotics (Table 1 ). (hindawi.com)
  • MRSA (Methicillin-Resistant Staphylococcus aureus ) is a strain of Staphylococcus aureus bacteria that has developed resistance to an entire class of antibiotics (called beta lactams), including methicillin, penicillin, amoxicillin, and oxacillin. (bioedonline.org)
  • The Government has a requirement to design and conduct a multi-site Phase II/III clinical trial for Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). (nih.gov)
  • The objective of a contract will be to advance the field of clinical management for uncomplicated skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) and to determine the optimal outpatient treatment strategy. (nih.gov)
  • Data are limited on the impact of methicillin-resistant Staphylococcus aureus (MRSA) on morbidity and mortality among very low birth weight (VLBW) infants with S aureus (SA) bacteremia and/or meningitis (B/M). (nih.gov)
  • Outcomes were compared for infants with MRSA versus methicillin-susceptible S aureus (MSSA) B/M. (nih.gov)
  • Cultures from the elbow and rear limb grew methicillin-resistant Staphylococcus aureus (MRSA). (vin.com)
  • The global and national burden of communicable and noncommunicable diseases continues to rise, thus making access to Healthcare workers (HCWs) colonized with methicillin-resistant Staphylococcus aureus (MRSA) may pose transmission risk to vulnerable patients including neonates. (who.int)
  • Neonatal intensive care unit (NICU) patients are at high risk of acquiring colonization and infection by Methicillin-resistant Staphylococcus aureus (MRSA) (1). (who.int)
  • Teixobactin is a first member of newly discovered natural antibiotics that was recently identified from a hitherto-unculturable soil bacterium, Eleftheria terrae, and recognized as a potent antibacterial agent against various Gram-positive bacteria, including methicillinresistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci. (monash.edu)
  • In the present study, metabolomics was used to investigate the potential metabolic pathways involved in the mechanisms of antibacterial activity of the synthetic teixobactin analogue Leu10-teixobactin against a MRSA strain, S. aureus ATCC 700699. (monash.edu)
  • Strains of S. aureus can be either methicillin-resistant (MRSA) or methicillin-susceptible (MSSA). (vin.com)
  • But MRSA strains are not just resistant to methicillin, they're resistant to all the antibiotics in the same drug family as methicillin (the beta lactams), including many common drugs such as penicillins and cephalosporins. (vin.com)
  • Some strains of MRSA are also resistant to other families of antibiotics, which can make them extremely difficult to treat. (vin.com)
  • All MRSA strains are resistant to beta-lactam antibiotics, but because different strains may be resistant to other antibiotics as well, the bacteria must be tested in order to choose the best antibiotic. (vin.com)
  • Automatically choosing the most powerful antibiotic to treat the infection when a more common drug will do can be dangerous - and expensive - because the MRSA, or other bacteria in the body, may become resistant to it, and then there may be no drug that can effectively treat it. (vin.com)
  • We performed antimicrobial drug susceptibility testing and molecular typing on invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 1,666) submitted to the University of Iowa Hygienic Laboratory during 1999-2006 as part of a statewide surveillance system. (cdc.gov)
  • Methicillin resistant Staphylococcus aureus (MRSA) is one organism of particular concern, with the number of infections increasing in epidemic proportion. (unlv.edu)
  • Methicillin resistant Staphylococcus aureus (MRSA) is the leading pathogenic cause of nosocomial infections, especially in bacteraemia and sepsis. (biomedcentral.com)
  • The essential therapy for methicillin resistant S. aureus (MRSA) infections is glycopeptides (vancomycin or teicoplanin). (biomedcentral.com)
  • Methicillin resistant staphylococcus aureus infection can represent a hazard for equine health, and supports the opinion that inappropriate administration of antimicrobials and hospitalization/surgery represent risk factors for MRSA colonization and infection in horses. (chemijournal.com)
  • The susceptibility of 47 clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to cefpirome, ceftazidime and methicillin was determined with Isosensitest media, with/without 5% NaCl and incubation at 30 degrees, 37 degrees and 44 degrees C for 24 and 48 h. (birmingham.ac.uk)
  • Cefpirome had primary affinity for penicillin-binding protein (PBP) 1 and 2 in five MRSA and one methicillin-susceptible Staphylococcus aureus. (birmingham.ac.uk)
  • No cefpirome-resistant mutants could be selected from a methicillin-susceptible Staphylococcus aureus, but mutants were selected from an MRSA (expressing homogeneous methicillin resistance) for which MICs of cefpirome were 8 to 32 mg/l. (birmingham.ac.uk)
  • Background: Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high rates of treatment failure in adults. (johnshopkins.edu)
  • Methicillin-resistant Staphylococcus aureus (MRSA) is the name for the strains of staph bacteria … cause more serious infections like sepsis. (wisconsin.gov)
  • Resources Resources for individuals and families Methicillin-resistant Staphylococcus aureus (MRSA) Frequently Asked Questions (FAQ) : FAQ for patients and family members of patients with MRSA. (wisconsin.gov)
  • This is the first time this gene is being reported in S. aureus and this may increase the level and magnitude of resistance by MRSA. (projecttopics.com)
  • Resistant to penicillin and methicillin, CA-MRSA infections can still be treated with other common-use antibiotics. (oregonvma.org)
  • Methicillin-resistant Staphylococcus aureus (MRSA) is a global human health problem causing infections in both hospitals and the community. (worktribe.com)
  • The application of molecular detection methods for bacterial pathogens has dramatically improved the outcomes of septic patients, including those with methicillin-resistant Staphylococcus aureus (MRSA) infections. (udayton.edu)
  • Clinical treatment options for daptomycin (DAP)-resistant (DAP-R), methicillin-resistant Staphylococcus aureus ( MRSA ) infections are relatively limited. (bvsalud.org)
  • In November 2012, an outbreak of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections affecting students at a boarding school in Hong Kong (China) was detected. (who.int)
  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) outbreaks in schools usually affect members of sports teams who come into bodily contact with one another. (who.int)
  • The objective of this study were to determine antimicrobial activity of the S.alata extract on Methicillin-Sensitive S. aureus (MSSA) and Methicillin-Resistant S. aureus (MRSA). (tci-thaijo.org)
  • In this paper we present a study of the effectiveness of an atmospheric pressure plasma source, known as plasma needle, in inhibition of the growth of biofilm produced by methicillin resistant Staphylococcus aureus (MRSA). (edu.pl)
  • Methicillin-resistant Staphylococcus aureus , more commonly known as MRSA, is a type of Staphylococcus aureus that is resistant to a number of antibiotics including methicillin. (yourgenome.org)
  • MRSA (methicillin-resistant Staphylococcus aureus ) is a form of staphylococcal infection that is resistant to methicillin. (yourgenome.org)
  • Many of us live with Staphylococcus aureus and MRSA without any problems. (yourgenome.org)
  • A potential new antibiotic is highly effective against "superbugs" such as MRSA that are resistant to many existing antibiotics , and kills bacteria in an unusual way that means it will be extremely difficult for resistance to evolve. (newscientist.com)
  • At this point, no matter what happens with cephalosporins, resistant gonorrhea is on its way to winning out over available antibiotics, making it one of many worrisome bacterial strains, such as total-drug-resistant tuberculosis and MRSA, or methicillin-resistant Staphylococcus aureus . (latimes.com)
  • During the past four decades, methicillin-resistant Staphylococcus aureus, or MRSA, has evolved from a controllable nuisance into a serious public health concern. (medlineplus.gov)
  • Google queries were a useful predictor of hospitalizations for methicillin-resistant S. aureus infections. (medscape.com)
  • Staphylococcus aureus is the most common bacterial pathogen isolated from human infections. (medscape.com)
  • Among patients with skin or soft-tissue infections, therapy to which the infecting strain was resistant did not appear to be associated with adverse patient-reported outcomes. (nih.gov)
  • Staphylococcus aureus causes many skin and soft-tissue infections and invasive diseases such as sepsis, endocarditis, pneumonia, and osteomyelitis [ 2 ]. (hindawi.com)
  • These infections are complex to treat because this bacterial species can become resistant to antibiotics. (hindawi.com)
  • Among these invasive infections, necrotizing S. aureus pneumonia has emerged as one of the most lethal [ 4 , 5 ]. (hindawi.com)
  • Prevention and drug therapy of methicillin resistant Staphylococcus aureus infections]. (nih.gov)
  • Microbiological indications for the treatment of Staphylococcus aureus infections. (nih.gov)
  • Community-acquired methicillin-resistant Staphylococcus aureus infections are defined as the isolation of methicillin-resistant Staphylococcus aureus from the relevant disease process from subjects who have not been hospitalized within the previous fourteen (14) days. (nih.gov)
  • 1. Methicillin-resistant Staphylococcus aureus skin infections from an elephant calf-San Diego, California, 2008. (vin.com)
  • To conclude, this is the first study to provide novel metabolomics mechanistic information, which lends support to the development of teixobactin as an antibacterial drug for the treatment of multidrug-resistant Grampositive infections. (monash.edu)
  • Staphylococcus aureus is a virulent pathogen that is currently not only the most common cause of infections in hospitalized patients worldwide but increasingly also as a community associated pathogen. (projecttopics.com)
  • The identification of mecA and mecB genes in community isolates implies that any outbreak of infections caused by these strains may pose a threat to public health as these strains are resistant to all antibiotics tested except ciprofloxacin, vancomycin and co-trimoxazole. (projecttopics.com)
  • Staphylococcal infections are a group of infections caused by the bacterium Staphylococcus. (yourgenome.org)
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cubicin and other antibacterial drugs, Cubicin should be used only to treat or prevent infections caused by bacteria. (theodora.com)
  • Therefore, since it is a global public health problem involving several sectors, it also requires a global solution in the context of the One Health approach to achieve adequate control through the prevention, reduction, and mitigation of drug-resistant infections. (who.int)
  • Staphylococcus aureus infections range from mild to life threatening. (msdmanuals.com)
  • Resistant infections are emerging faster than new antibiotics. (latimes.com)
  • Health care providers commonly use the antibiotic vancomycin to treat Enterococcal infections, but VRE are resistant to the drug. (medlineplus.gov)
  • Some CRE infections are resistant to most available antibiotics and can be life-threatening. (medlineplus.gov)
  • A tube coagulase test using rabbit plasma with (ethylenedinitrilo) tetraacetic acid (EDTA) is then performed on Staphaurex-negative isolates from BAP with morphology consistent with S. aureus and Staphaurex-positive isolates with morphology inconsistent with S. aureus (non-hemolytic). (cdc.gov)
  • Staphaurex-positive isolates and Staphaurex-negative tube coagulase-positive isolates are identified as S. aureus and saved for further testing. (cdc.gov)
  • S. aureus isolates are screened for methicillin resistance following the National Clinical and Laboratory Standards Institute (NCCLS) disk diffusion method. (cdc.gov)
  • Of the 91 samples examined, 88 were coagulase positive staphylococci, which following biochemical characterization were classified as S.aureus (16 isolates) and S intermedius (72 isolates). (ijcmas.com)
  • Fourteen of the 88 isolates were found to be methicillin resistant of which 5 isolates were S aureus and 9 were S intermedius . (ijcmas.com)
  • Six of the methicillin resistant isolates (Four S intermedius and two S aureus as per biochemical characterization) were further subjected to DNA extraction and PCR targeting the mecA gene specific for methicillin resistance. (ijcmas.com)
  • None of the 33 isolates subjected to E-test was Vancomycin resistant. (projecttopics.com)
  • Phenotypic detection of methicillin resistance with the use of cefoxitin and oxacillin discs gave a prevalence of 79.5% (136/171) of the Staphylococcal isolates and 47.9% of S. aureus. (projecttopics.com)
  • These isolates were resistant to the betalactam antibiotics and were multidrug resistant. (projecttopics.com)
  • Sixteen of the S. aureus isolates had the mecA and nuc genes. (projecttopics.com)
  • The nucleotide sequence of 16S rRNA gene of the 16 isolates showed that 12 of them had 77-92% identity with S. aureus strain N315. (projecttopics.com)
  • Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance. (nih.gov)
  • It is purported that teixobactin's "resistance-resistant"mechanism of action includes binding to the essential bacterial cell wall synthesis building blocks lipid II and lipid III. (monash.edu)
  • Importantly, teixobactin significantly suppressed the main intermediate D-alanyl-D-lactate involved in the mechanism of vancomycin resistance in S. aureus. (monash.edu)
  • For the detection of mecA (methicillin resistance) and femA (S. aureus specific) genes, a multiplex PCR performed using primers. (chemijournal.com)
  • Antimicrobial resistance occurs through different mechanisms, which include spontaneous (natural) genetic mutations and horizontal transfer of resistant genes through deoxyribonucleic acid (DNA). (who.int)
  • Beta-lactam (β-lactam) antibiotics are a broad-spectrum group that include some penams (penicillin derivatives such as methicillin and oxacillin) and cephems such as the cephalosporins. (wikipedia.org)
  • Strains unable to resist these antibiotics are classified as methicillin-susceptible S. aureus, or MSSA. (wikipedia.org)
  • When this occurs, the germ is said to be resistant to certain antibiotics. (nih.gov)
  • Post-cesarean delivery infectious morbidity: Focus on preoperative antibiotics and methicillin-resistant Staphylococcus aureus. (musc.edu)
  • It is often resistant to other commonly used antibiotics as well. (yourgenome.org)
  • Agricultural use isn't necessarily related to resistant gonorrhea, a "wily" disease, as the CDC researchers put it, with a history of quickly outwitting available antibiotics. (latimes.com)
  • Antibiotic treatment can alter the microbiota that allows C. difficile, a bacterium that is naturally resistant to many common antibiotics, to grow and cause inflammation in the colon. (medlineplus.gov)
  • Complete Genome Sequences of Two Methicillin-Susceptible Staphylococcus aureus Clinical Strains Closely Related to Community-Associated Methicillin-Resistant S. aureus USA300. (pacb.com)
  • To help understand the emergence of this highly successful strain, we sequenced the genomes of two methicillin-susceptible Staphylococcus aureus clinical strains that are very closely related to USA300. (pacb.com)
  • Staphylococcus aureus is one of the most common causes of skin and soft tissue infection in both the health care and community settings. (cdc.gov)
  • Typically it causes no problems, but it is an opportunistic pathogen - if a pet or person gets injured or sick, S. aureus can take advantage of the body's weakened defenses and cause infection. (vin.com)
  • Skin infection is a common public health problem mostly caused by Staphylococcus aureus . (tci-thaijo.org)
  • It is a rare but life-threatening infection caused by Staphylococcus aureus releasing a toxic substance. (yourgenome.org)
  • Staphylococcus aureus (staph) is a type of bacteria found on people's skin. (cdc.gov)
  • Objective: Antimicrobial resistant bacteria (AMR) are of public health and economic relevance. (uni-muenchen.de)
  • The spread of antibiotic resistant bacteria is a major public health concern, as they result in greater healthcare costs and increased morbidity and mortality rates. (unlv.edu)
  • Multidrug-resistant bacteria in unaccompanied refugee minors arriving in Frankfurt am Main, Germany. (edu.krd)
  • Septic arthritis: a condition where a joint becomes infected with Staphylococcus aureus bacteria causing joint swelling, pain and fever. (yourgenome.org)
  • Staphylococcus aureus is the most dangerous of all of the many common staphylococcal bacteria. (msdmanuals.com)
  • However, some bacteria are becoming resistant to the two most potent TB drugs. (medlineplus.gov)
  • CRE is a family of highly resistant bacteria that includes Klebsiella species and Escherichia coli (E. coli). (medlineplus.gov)
  • Predominant community-associated methicillin-resistant Staphylococcus aureus strain USA300 is believed to have originated from an ancestral methicillin-susceptible strain, although the details of that evolution remain unknown. (pacb.com)
  • New 'superbug' strain of gonorrhea resistant to all. (latimes.com)
  • A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN . (bvsalud.org)
  • 51: Vancomycin-Resistant Enterococci. (gale.com)
  • Staphylococcus aureus is one of the most common human pathogens. (hindawi.com)
  • Bacterial cells of Staphylococcus aureus, which is one of the causal agents of mastitis in dairy cows. (bioedonline.org)
  • These were further subjected to sensitivity testing for Methicillin / Oxacillin by disc diffusion as per standard procedures. (ijcmas.com)
  • Despite advances in antistaphylococcal drugs, S. aureus sepsis is one of the most important causes of death [ 5 ]. (biomedcentral.com)
  • Novel Multiplex PCR Assay for Detection of the Staphylococcal Virulence Marker Panton- Valentine Leukocidin Genes and Simultaneous Discrimination of Methicillin- Susceptible from -Resistant Staphylococci. (edu.krd)
  • they were then plated on mannitol salt agar (MSA), a selective media for the isolation of S. aureus . (cdc.gov)
  • Molecular characterization of Sarcoptes scabiei and Methicillin-resistant Staphylococcus aureus among internally displaced children in UNHCR Refugee-IDP camp. (edu.krd)
  • Staphylococcus aureus, often called Staph aureus or S. aureus, is a bacterium that is normally carried in the nose of about 30% of the general human population. (vin.com)
  • citation needed] In humans, Staphylococcus aureus is part of the normal microbiota present in the upper respiratory tract, and on skin and in the gut mucosa. (wikipedia.org)
  • This study was aimed at determining the prevalence of methicillin resistant S. aureus among apparently healthy student population of the University of Jos, Jos Nigeria. (projecttopics.com)
  • We describe a 44-year-old man who developed toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus while pancytopenic after chemotherapy. (edu.au)
  • Antimicrobial resistant microorganisms are found in people, animals and the environment and can spread globally. (who.int)
  • Of the 217 samples collected 171 (78.8%) were positive for Staphylococcal species while 73(54.1%) of 135 screened with the MicrogenD test kit were identified as S. aureus. (projecttopics.com)
  • Endocarditis: this is when Staphylococcus infects the internal structures of the heart (for example, the heart valves), causing inflammation . (yourgenome.org)
  • On the growing roster of antibiotic-resistant diseases, gonorrhea is the one that has most recently captured the attention of public health officials. (latimes.com)
  • Because Staphylococci are highly resistant to lysis with standard agents, such as lysozyme or detergents, lysostaphin has been widely used in research laboratories as a staphylolytic agent. (hindawi.com)
  • These gains of antibiotic therapy are now seriously jeopardized by the emergence and spread of microbes that are resistant to cheap and effective first-choice or "first-line" drugs. (projecttopics.com)
  • However, herpes gladiatorum, methicillin-resistant Staphylococcus aureus , and chickenpox all may cause severe disease, and infected wrestlers should be disqualified. (healthychildren.org)
  • Drug-resistant gonorrhea spreading rapidly in U.S. (latimes.com)
  • Here is a list of some of the leading antimicrobial drug-resistant organisms NIAID is researching. (medlineplus.gov)
  • This is known as multi-drug-resistant TB (MDR TB). (medlineplus.gov)
  • We assessed the potential for Internet-based surveillance of methicillin-resistant Staphylococcus aureus and examined the extent to which it reflects trends in hospitalizations and news coverage. (medscape.com)
  • Cite this: Internet Queries and Methicillin-Resistant Staphylococcus aureus Surveillance - Medscape - Jun 01, 2011. (medscape.com)